WO2009022761A1 - Dissolvable nano web porous film and method of preparing the same - Google Patents

Dissolvable nano web porous film and method of preparing the same Download PDF

Info

Publication number
WO2009022761A1
WO2009022761A1 PCT/KR2007/004342 KR2007004342W WO2009022761A1 WO 2009022761 A1 WO2009022761 A1 WO 2009022761A1 KR 2007004342 W KR2007004342 W KR 2007004342W WO 2009022761 A1 WO2009022761 A1 WO 2009022761A1
Authority
WO
WIPO (PCT)
Prior art keywords
agents
porous film
derivatives
nano
film
Prior art date
Application number
PCT/KR2007/004342
Other languages
French (fr)
Inventor
Hyun-Oh Yoo
Tae-Won Son
Original Assignee
Genic Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genic Co., Ltd. filed Critical Genic Co., Ltd.
Priority to EP07808135.3A priority Critical patent/EP2187970A4/en
Priority to CN2007801007557A priority patent/CN102014962B/en
Priority to US12/672,950 priority patent/US20110250256A1/en
Publication of WO2009022761A1 publication Critical patent/WO2009022761A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00General methods for the manufacture of artificial filaments or the like
    • D01F1/02Addition of substances to the spinning solution or to the melt
    • D01F1/10Other agents for modifying properties
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present invention relates to a dissolvable nano web porous film that is biologically or physiologically applicable, and a method of preparing the same. More particularly, the present invention relates to a nano web porous film that has a nano web network structure and a large specific surface area and a method of preparing the same.
  • conventional edible nonporous films are produced in such a fashion of: dissolving polymers such as starch, pullulan, etc., and materials which include film forming agents, plasticizer, flavoring agents, sulfur precipitating agents, saliva stimulating agents, cooling agents, surfactants, stabilizing agents, emulsifying agents, thickening agents, binding agents, coloring agents, pigments, sweeteners, fragrances, antimicrobial agents, etc. in a solvent such as water to provide a mixture thereof; forming the mixture into a film, followed by drying the film; cutting the obtained film to pieces of the film having a proper size; and putting them in a container.
  • dissolving polymers such as starch, pullulan, etc.
  • materials which include film forming agents, plasticizer, flavoring agents, sulfur precipitating agents, saliva stimulating agents, cooling agents, surfactants, stabilizing agents, emulsifying agents, thickening agents, binding agents, coloring agents, pigments, sweeteners, fragrances, antimicrobial agents, etc. in a solvent such as water
  • the conventional edible nonporous films require excellent dissolvability in a mouth such that the films are easily liquefied in the mouth, and drying resistance whereby the films are not cracked or curled. Further, the films should not become sticky due to absorption of moisture or heat.
  • Such a thin nonporous film tends to absorb moisture, which causes sticking of the film.
  • the film tends to absorb moisture or tends to be dissolved at high temperature and humidity, and thus it can easily become sticky in the summer.
  • JP Patent Publication No. 1999-116469 disclose a film capable of being quickly dissolved in the mouth.
  • JP Patent Publication No. 1993-236885 discloses an edible film as a vehicle to carry flavoring and refreshing food without attracting public attention, and a film that contains pullulan and carrageenan to improve drying resistance.
  • these films have low resistance to moisture and suffer from sticking in highly humid conditions.
  • US Patent No. 3,784,390 discloses pullulan films and their use in coating and packing materials for foods, pharmaceuticals and other oxygen sensitive materials.
  • US Patent No. 4,623,394 discloses a method of preparing a film with pullulan.
  • US Patent No. 7,067,116 discloses products of edible films which include pullulan binders, polysaccharides, antibacterial agents, flavor-imparting agents, and pharmaceutically active components.
  • US Patent No. 6,528,088 discloses a film that contains modified starch, such as etherified starch or esterified starch, and plasticizers mixed with the starch in the ratio of at least 0.5: 1 by weight to increase the plasticity of the film.
  • modified starch such as etherified starch or esterified starch
  • plasticizers mixed with the starch in the ratio of at least 0.5: 1 by weight to increase the plasticity of the film.
  • a high plasticizer content of the film causes an unpleasant feeling in the mouth and insufficient sticking resistance.
  • US Patent No. 6,656,493 discloses a film that contains sodium alginate and mal- todextrin. Maltodextrin having a low molecular weight is added to the films to improve dissolution in the oral cavity. However, as the concentration of maltodextrin increases, moisture resistance of the film decreases, causing easy sticking thereof. The drying resistance of the films is also not satisfactory.
  • US Patent Application Publication No. 2003/0099692 discloses a film that includes processed starch as a main ingredient.
  • the starch is cross-linked and chemically processed as in acetyl, ester, hydroxyethyl and hydroxyproply derivatives of starch. Further, derivatives of starch by oxidation, enzyme conversion, acid hydrolysis, etc. may also be used in forming the film.
  • the processed starch is substantially independently used, and thus the film does not have sufficient sticking resistance.
  • WO 98/26763 discloses a film for use in the oral cavity, which may contain a cosmetic or pharmaceutical active component
  • WO 01/70194 discloses a rapidly dissolvable edible film that contains an ion exchange resin as a taste masking agent
  • WO 98/20862 also discloses a film for use in the oral cavity, which may contain a cosmetic or pharmaceutical active component
  • WO 99/17753 discloses a rapidly soluble film for delivering medical supplies to be absorbed in a digestive tract
  • US Patent No. 6,596,290 discloses the delivery of pharmaceutical agents in an edible film vehicle.
  • US Patent No. 5,935,883 discloses a process of producing a superfine microfiber split web using a melt-blown device.
  • US Patent No. 6,057,256 discloses formation of a coherent entangled web by blowing a polymer solution in a collector.
  • US Patent No. 6,106,913 discloses a web produced with a fiber of 1 nm using the combination of an electro spinning method and an air vortex spinning method.
  • US Patent No. 6,110,509 discloses a biodegradable silk web having a diameter ranging from 2 to 2000 nm using an electro spinning method.
  • KR patent publication No. 2001-0031586 discloses a process of massively preparing a nano-sized nanofiber web by organically combining a melt-blown method and an electrostatic spinning method.
  • KR patent publication No. 2001-0031587 discloses a process of preparing a nanofiber web by organically combining a flash spinning method and an electrostatic spinning method.
  • KR patent publications Nos. 2003-0077384 and 2004-0040692 disclose a method of producing a superfine nanofiber web which is improved in productivity and yield by combination of the melt-blown spinning method and the electrostatic spinning method.
  • the present invention has been made to solve the foregoing problems of the prior art and therefore an aspect of the present invention is to provide a dissolvable nano web porous film that is biologically and physiologically applicable.
  • Another aspect of the invention is to provide a dissolvable nano web porous film that is quickly dissolved in saliva in administration into the oval cavity or fluid secreted from the skin.
  • a further aspect of the present invention is to provide an edible nano web porous film, of which active component is absorbed into the body and which is edible without water.
  • Yet another aspect of the present invention is to provide a nano web porous film that has superior dissolvability, drying resistance, and sticking resistance.
  • Yet another aspect of the present invention is to provide a dissolvable nano web porous film where an active component and the film are capable of being rapidly decomposed or dissolved.
  • Yet another aspect of the present invention is to provide a method of preparing a dissolvable nano web porous film having the foregoing properties.
  • the present invention provides a dissolvable nano web porous film having a network structure, wherein the network structure is formed by stacking nano fibers, the nano fibers having a thickness of 10-50,000 nm and formed of a composition composed of (A) a nano fiber forming polymer, (B) a gelling agent, and (C) a plasticizer.
  • the present invention provides a method of preparing a dissolvable nano web film, comprising: (1) forming a polymer melt or solution of a composition composed of (A) a nano fiber forming polymer, (B) a gelling agent and (C) a plasticizer, as essential ingredients, and (D) active components, and (E) a ⁇ tives, as optional ingredients; (2) spinning the melt or solution to form a nano web porous film having nano webs stacked in a three-dimensional network structure; (3) drying the nano web porous film; and (4) stabilizing the nano web porous film.
  • the dissolvable nano web porous film has a 5-5000 times lager specific surface area and a 2-20 times faster dissolving time than a conventional film.
  • the dissolvable nano web porous film is excellent in dissolvability and solubility.
  • the dissolvable nano porous film is used for a medicine to be edible without water.
  • the film is rapidly dissolvable and liquefied by saliva in the oral cavity, the medicine is absorbed into the bloodstream through a mucous membrane in the oral cavity without any displeasure.
  • the medicine is absorbed into the bloodstream without passing through the stomach and gullet, it is advantageous in rapidly providing therapeutic effects.
  • the dissolvable nano porous film according to the present invention can be preferably used as a carrier for functional foods, drugs, plant extracts, etc. which have a very small quantity of effective ingredients.
  • the dissolvable nano web porous film is provided along with emulsified fat- soluble flavors and emulsified oils and fats to be used as a mouth-freshening nano web porous film or a flavor nano web porous film for bad breath prevention, refreshment, improvement of edibility, nutrients supplementation, drug delivery, improvement of health, etc.
  • these films can be a substitute for gum, candies, a spray type oral cleansing agent, a breath freshening agent, and the like.
  • the dissolvable nano web porous film is dissolved by fluid secreted from the skin or moisture to be rapidly soluble and liquefied, medicines or functional materials are absorbed epidermally and percu- taneously without displeasure. Accordingly, therapeutic effects are quickly exhibited, and thus the film can be useful for skin care, therapy for skin, etc.
  • the dissolvable nano web porous film is provided along with a bleaching agent or a dental bleaching agent to be used as a dental bleaching film.
  • Fig. 1 is a mimetic diagram of a portion of a network structure on the surface of a dissolvable nano web porous film according to an exemplary embodiment of the present invention, in which reference numeral 1 indicates a cross section of a nano fiber in the dissolvable nano web porous film, and reference numeral 2 indicates a pore between the nano fibers;
  • FIG. 2 is a micrograph of the surface of the nano web porous film taken by a scanning electron microscope (SEM) according to a first exemplary embodiment of the present invention, illustrating that plural nano fibers are stacked to form a nano web where a network structure and pores exist;
  • Fig. 3 is an enlarged SEM image of a portion of the surface of the dissolvable nano web porous film according to the first exemplary embodiment of the present invention;
  • Fig. 4 is a highly enlarged SEM image of a portion of the surface of the dissolvable nano web porous film according to the first exemplary embodiment of the present invention
  • Fig. 5 is an SEM image of the cross section of the dissolvable nano web porous film according to the first exemplary embodiment of the present invention.
  • Fig. 6 is an SEM image of the surface of a nonporous film according to a second exemplary embodiment of the present invention.
  • Fig. 7 is an SEM image of the cross section of the nonporous film according to the second exemplary embodiment of the present invention.
  • Fig. 8 is a graph illustrating the relation (i.e., dissolvability in tepid water and in the oral cavity) between the dissolving time and the thickness of the dissolvable nano web porous film according to the first exemplary embodiment of the present invention and the relation between the dissolving time and the thickness of the nonporous film according to the second exemplary embodiment of the present invention.
  • the present invention relates to a dissolvable nano web porous film that can be rapidly dissolved by saliva in the oral cavity or fluid secreted from the skin, and a method of preparing the same.
  • the nano web porous film has a large surface area, pores and a rapidly soluble network structure capable of rapidly responding to materials from the outside, and is rapidly dissolved by the saliva in the oral cavity or the fluid secreted from the skin. Due to the film's rapid dissolvability, active components (e.g., drugs and the like) in the film can be more effectively absorbed into the body. Also, the film has edibility to allow the film to be edible without water and without any displeasure in a dissolved state, dissolvability, drying resistance, and sticking resistance.
  • the dissolvable nano web porous film according to the exemplary embodiment of the present invention has a network structure where nano fibers having a thickness of 10-50,000 nm are stacked.
  • the nano fibers are formed of a composition composed of (A) a nano fiber forming polymer, (B) a gelling agent, and (C) a plasticizer. If the nano fiber has a thickness less than 10 nm, it is difficult to me- chanically produce the film. If the nano fiber has a thickness more than 50,000 nm, the film has reduced dissolvability.
  • the nano web porous film is preferably formed to have a thickness of 5-500 ⁇ m to obtain excellent properties in view of drying resistance, feeling in the oral cavity, dissolvability in the oral cavity, etc.
  • the nano web porous film preferably has porosity ranging from 10-90%. If the porosity is less than 10%, it is difficult to mechanically produce the film. If the porosity is more than 90%, it is difficult to form a nano web.
  • the nano web porous film preferably has a specific surface area in the range of 1-1,000 mVg. If the specific surface area is less than 1 mVg, the film may not exhibit excellent dissolvability. If the specific surface area is more than 1,000 mVg, it is difficult to mechanically produce the film.
  • the dissolvable nano web porous film [50] According to the present invention, the dissolvable nano web porous film
  • nano fibers having a composition that essentially consist of (A) a nano fiber forming polymer, (B) a gelling agent, and (C) a plasticizer.
  • the composition, which forms the nano fiber may further comprise (D) an active component andhr (E) other a ⁇ tives according to use of the porous film, if necessary.
  • the nano fiber forming polymer (A) an ingredient of the composition for forming the (dissolvable and/ ⁇ r edible) nano web porous film, is a main ingredient for the nano fiber and the nano web porous film, and carries active components in a nano web.
  • nano fiber forming polymer (A) used to form the film of the invention examples include, but are not limited to, pullulan, hjdroxypropylmethyl cellulose (HPMC), hylroxymethyl cellulose (HMC), hylroxyethyl cellulose (HEC), hy- droxypropyl cellulose (HPC), ethyl cellulose (EC), methyl cellulose (MC), hjdrox- ypropylmethyl cellulose phthalate (HPMCP), hyiroxypropylmethyl cellulose acetate succinate (HPMCAS), cellulose acetate phthalate (CAP), carboxymethyl cellulose (CMC), polyvinyl pyrrolidone (PVP), polyvinyl alcohol (PVA), sodium alginate, polyethylene glycol, locust bean gum, xanthan gum, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methyl methacryl
  • the nano fiber forming polymer (A) has an average molecular weight of 1,000-2,000,000 g/mol. If the average molecular weight is less than 1,000 g/mol, the viscosity of the polymer is low, making it difficult to form a nano web. If the average molecular weight is more than 2,000,000 g/mol, the viscosity is high, making it difficult to process the polymer. In addition to the aforementioned polymers, any of known hydrophilic natural polymers having an average molecular weight of 1,000-2,000,000 g/mol may be used to form the film of the invention.
  • the nano fiber forming polymer (A) is added in an amount of l ⁇ 99wt%, and preferably, of about 15 ⁇ 80wt%, to the composition of the nano web porous film. If the polymer content is less than lwt%, it is difficult to form a fiber. And, since other solvents or ingredients should also be mixed in formation of the nano fiber, the polymer content may be added up to 99wt%.
  • composition [55] The other ingredients (specifically, the gelling agent, plasticizer, active ingredients, additives, and water) of the composition are added to the composition according to proposed contents and conditions, which will be described below.
  • the gelling agent an ingredient of the composition to form the dissolvable nano web porous film, is used to prevent the nano web porous film from breaking, and becomes gel when cooled.
  • the gelling agent include, but are not limited to, a natural gelling agent, such as locust bean gum, xanthan gum, carrageenan, gelatin, gellan gum, agar, alginates, guar gum, starch, pectin, ethyl cellulose, methyl cellulose, sodium carboxymethyl cellulose, polyethylene glycol, and combinations thereof. Also, a mixture of two or more aforementioned materials may be used as the gelling agent.
  • a mixing ratio of the gelling agent (B) to 100wt% polymer (A) is in the range of about 0.1 ⁇ 50wt% (for example, 0.1-50 parts by weight gelling agent to 100 parts by weight polymer), and preferably, of 0.4 ⁇ 30wt%. If the mixing ratio is below the range, the film tends to be curled. Conversely, if the ratio exceeds the range, the film has low dissolvability.
  • the plasticizer is used to endow the film with properties of hardening prevention, sticking prevention, and plasticity.
  • the plasticizer also drops the glass transition temperature of the film during the process, thereby adjusting the melting viscosity thereof.
  • the plasticizer includes, but are not limited to, sorbitol, mannitol, glycerin, propylene glycol, polyethylene glycol, fatty acid glycerol monoester, sugar alcohol, monosaccharide, oligosaccharide, Methylene glycol, myvacet, triethyl citrate, triacetin, propylene glycol monocaprylate, propylene glycol dicaprylate, miglyol, etc., all of which are organic compounds of polyol containing at least one hjdroxyl group.
  • alcohol-based or polyol-based organic compounds induing at least one hjdroxyl group may be used as the plasticizer. These materials are used independently or together. A mixture of two or more aforementioned materials may be used as the plasticizer.
  • a mixing ratio of the plasticizer (C) to 100wt% polymer (A) is in the range of about 0.1 ⁇ 40wt% (for example, about 0.1- 40 parts by weight plasticizer to 100 parts by weight polymer). If the mixing ratio is below the range, the film deteriorates in drying resistance. If the ratio is above the range, the film deteriorates in sticking resistance.
  • the composition may further comprise an active component as necessary.
  • the active component comprises food, medicines, drugs, functional materials, etc., which promote structural and functional modifications in the body to which it is administered.
  • the active component is not specifically limited, but provided as any of materials which are physiologically applicable, mixable with other materials of the nano web porous film, and have activity corresponding to uses of the film.
  • the active component include, but are not limited to, one selected from the group or type consisting of: ⁇ -adrenergic agonists; ⁇ -adrenergic agonists; ⁇ -adrenergic blocking agents; ⁇ -adrenergic blocking agents; alcohol prohibition agents; aldose-reductase inhibitors; anabolic agents; narcotic analgesics; derivatives of morphine; non-narcotic analgesics, preferably, salicylates and derivatives thereof; androgens; anesthetics; appetite inhibitors; anthelmintics (taenia, nematode, filarial, schistosome, and fluke eliminating active agents); antiacne agents; antiallergic agents; antiamebic drugs (ameba eliminating agents); antiandrogens
  • the active component is an optional ingredient and selectively added according to purposes of the nano web porous film.
  • the active component is not limited to the aforementioned materials, but may employ drugs which can be pharmaceutically activated.
  • the active component is not specifically limited to a certain component, so long as it is capable of being dissolved in water or ethanol. A proper dosage of the active component is 0.001-50 mg.
  • the dissolvable nano web porous film is edible without water, and rapidly dissolved and liquefied by saliva in the oral cavity, so that drugs may be absorbed into the body without any displeasure. Even in this case, it is desirable to use an active component (drugs and the like) which does not have ill-affect on digestive organs, the mucous membrane in the oral cavity, and the like.
  • the active component is optionally provided up to 40wt%, and preferably, 0.01 ⁇ 40wt%, with respect to the total weight of the final film.
  • the active component does not have any lower limit in content, but can be added in a content of 0.01wt% or more with respect to the final film so as to exhibit its properties by the addition. If the content of the active component exceeds 40wt%, it is difficult to form a nano web.
  • additives may be optionally added to the composition for the dissolvable nano web porous film to improve properties required for the film.
  • the additives include, but are not limited to, flavoring agents, sulfur precipitating agents, saliva stimulating agents, cooling agents, surfactants, stabilizing agents, emulsifying agents, thickening agents, binding agents, coloring agents, pigments, sweeteners, fragrances, germicides, antimicrobial agents, pharmaceutical active agents, etc.
  • the additives may be provided as, but are not limited to, saccharides to improve taste (all typical saccharides, for example, but not limited to, white sucrose, maltose, fructose, galactooligosaccharide, galactose, fructooligosaccharide, dextrin, ion starch syrup, malt syrup, lactose, glucose, sorbitol, mannitol, xylitol, inositol, etc.); saliva stimulating agents (e.g., but not limited to, citric, lactic, maleic, succinic, ascorbic, adipic, fumaric, and tartaric acids); sweeteners (e.g., but not limited to, monosaccharide, disaccharide, ribose, glucose, mannose, galactose, fructose, sucrose, maltose, invert sugars, corn syrup solids, glythyl retinoate
  • the additives are provided up to 40wt%, and preferably, in the range of
  • the additives do not have a lower limit in content, but should be added in a content of 0.01wt% or more with respect to the final film so as to exhibit its properties by the addition. If the content of additives exceeds 40wt%, it is difficult to form a nano web.
  • composition is melted or dissolved to form a polymer melt or polymer solution.
  • the polymer melt or solution is spun into nano fibers, and the fibers are stacked, thereby producing a nano web porous film in a network structure according to the present invention.
  • the method of preparing the nano web porous film according to the present invention will be described in detail.
  • a composition which comprises (A) a nano fiber forming polymer, (B) a gelling agent, and (C) a plasticizer, as essential ingredients, and (D) an active component and/ or (E) additives, as optional ingredients, is melted or dissolved to prepare a polymer melt or polymer solution.
  • (A) to (E) ingredients may be added regardless of order, which is adjusted by those skilled in the art in consideration of properties and characteristics thereof.
  • a single or two or more ingredients may be melted or dissolved according to proper selection by those skilled in the art in consideration of the properties and characteristic thereof.
  • a polymer solution can be produced by the following process: dissolving or dispersing (A) a nano web film forming polymer in a solvent in an amount of about 1.5-4.5 times the total amount of the polymer at room temperature or a certain temperature, adding (B) a gelling agent and (C) a plasticizer thereto, followed by dissolving them, and dissolving and dispersing (D) an active component and (E) additives as necessary.
  • water is generally used as a solvent.
  • the polymer melt or polymer solution is spun into nano fibers.
  • the spinning process is performed by, for example, spun-lace, spun-bond, melt-blown, flash spinning, electro spinning, etc.
  • the nano fibers are formed in the form of non- woven fabrics by spinning the polymer melt or polymer solution.
  • a nano web is produced in a network structure where a great number of nano fibers are stacked.
  • the nano fibers are stacked or wound evenly such that the nano web has a uniform overall thickness.
  • the nano web having the network structure where the plural nano fibers are stacked or wound evenly can be used as a porous film of the present invention.
  • a solid content of the polymer melt or polymer solution is preferably adjusted to a concentration of about 15 ⁇ 50wt%. If the solid content is less than 15wt%, it is difficult to form a nano web due to low viscosity. If the solid content is more than 50wt%, it is difficult to form a stream of polymer melt or polymer solution using electric force due to high viscosity.
  • the spinning process is performed, but is not limited to, as follows.
  • the polymer melt or polymer solution is stored in a syringe, and is pressurized at a constant pressure by means of a syringe pump. Then, the pressurized polymer melt or solution in a liquid phase is pushed out through a minute opening (an inner diameter of 0.1-2 mm) of a nozzle tip in a spinning unit via an inlet pipe.
  • the solvent is volatilized or congeals, and nano fibers are stacked or wound on the surface of a collector (e.g., drum) disposed at a predetermined distance, thereby forming the nano web having the network structure.
  • a collector e.g., drum
  • the nano web of the network structure it is possible to regulate the porosity of the nano web, the diameter, size and form of the nano fiber, the thickness of the nano web, etc. by controlling some factors (e.g., the diameter of the nozzle tip, the intensity of electric field, the distance between the nozzle tip and the collector, the discharging speed of the melt/solution, the number of nozzles, the discharging amount of the melt/solution, the spinning time, etc.).
  • the nano web is spun and stacked to have a thickness of about 5-500 ⁇ m in order that the dissolvable nano web porous film has excellent drying resistance, feeling in the oral cavity, dissolvability in the oral cavity, and other properties.
  • a network structure nano web of nano fibers which are formed of different kinds of compositions mixed to exhibit different functions and effects, may be stacked and/ ⁇ r wound to produce a multilayer film that has a variety of properties.
  • the nano webs formed of the nano fibers and having the network structure are stacked to form the porous film, while being adjusted in thickness, density, and porosity thereof. If the nano webs are formed desired thick and densely, the nano webs themselves may be used as the nano web porous film without compression process. Optionally, the nano webs of the network structure formed at the process (2) are compressed to a desired thickness, if necessary to produce the nano web porous film.
  • the nano web porous film has a thickness of 5-500 ⁇ m, and preferably, of about 10-200 ⁇ m, to obtain excellent properties relating to drying resistance, feeling in the oral cavity, dis solvability in the oral cavity, etc.
  • the nano web film formed in a film type is dried by hot air at about 80-110 0 C so as to have a moisture content of 5 ⁇ 20wt%. If the drying temperature is less than 8O 0 C, the solvent is not likely to be volatilized, and the film is not dried rapidly. If the temperature is more than 11O 0 C, the film can be deformed. Also, if the moisture content of the film is less than 5wt%, it can be easily broken, whereas, if the content is more than 20wt%, the film is likely to droop and become sticky.
  • the dried nano web porous film is kept in a humidity adjusted space or in a thermo- hygrostat to stabilize the moisture content, and the like.
  • the stabilization is performed to allow the nano web porous film to have a moisture content of about 5- 15wt% so as to achieve optimal properties relating to feeling in the oral cavity, preservative performance, etc. If the stabilized final porous film has the content of moisture less than 5wt%, it can be easily broken. If the moisture content of the film is more than 15wt%, it tends to droop, and becomes sticky.
  • the stabilization is preferably performed at a temperature of 20 ⁇ 30°C and a relative humidity of 40-50% for 1 to 48 hours in order to achieve optimal properties of the film. It should be noted that the present invention is not limited to the aforementioned stabilization conditions. For example, the stabilization can be generally performed at a temperature of 25 0 C and a relative humidity of 45% for 24 hours.
  • Fig. 1 is a mimetic diagram of a portion of the network structure on the surface of the dissolvable nano web porous film according to an exemplary embodiment of the invention.
  • Reference numeral 1 indicates a cross section of a nano fiber in the dissolvable nano web porous film
  • reference numeral 2 indicates a pore formed between the nano fibers.
  • the nano web porous film of the network structure comprises a plurality of nano fibers (1), which have a diameter of several to tens of thousands of nanometers and a plurality of pores (2) formed among the nano fibers, it has very high specific surface area and porosity per weight.
  • the porous film of the invention has the nano web structure which is constituted by the network structure and the pores, the porous film has excellent surface activity and dis- solvability.
  • the active components drug and the like
  • carriers or other additives in the film are rapidly dissolved and/ ⁇ r melted by saliva in the oral cavity or fluid secreted from the skin, so medicines or other active components can be more quickly discharged in the oral cavity or on the skin.
  • the porous film exhibits rapid dissolution with a dissolution time in the range of 1-60 seconds, and excellent dis- solvability, which is twice to twenty times higher than that of the conventional nonporous film.
  • the dissolvable nano web porous film is decomposed and easily dissolved by reaction with amylase of saliva in the oral cavity.
  • the dissolvable nano web porous film exhibits excellent dis solvability and rapid dissolution, particularly in the oral cavity.
  • the edible nano web porous film of the invention may be used as a package or carrier to carry functional foods, vitamins, essential minerals, drugs, etc., which can be taken through the oral cavity. Also, since flavoring agents, refined oil, etc. are added to the porous film when it is formed, the porous film can be used as a flavoring carrier. Thus, the film can be used in new forms for health improvement, such as bad breath prevention, refreshment, improvement of edibility, nutrients supplementation, drug delivery, health food supplement, etc.
  • the dissolvable nano web porous film is produced including active components such as drugs, it can be formed as an edible material, which is edible without water.
  • the porous film exhibits edibility to be rapidly dissolved and liquefied by saliva in the oral cavity, so that medicines can be absorbed in the body without any displeasure.
  • the porous film is excellent in view of dissolvability, drying resistance, and sticking resistance, which are fundamental properties required for a dissolvable film.
  • the porous film is biologically and physiologically applicable. That is, the porous film has a solubility that is physiologically allowable in the skin and mucous membranes such as the oral cavity, the gullet, etc.
  • the conventional nonporous film should have a certain thickness to perform intended functions, e.g., to load active components.
  • the thickness of the film must be determined by the properties and amount of the active components to be discharged from the film.
  • an increase in thickness of the film leads to a decrease in decomposition and dissolution rates of the nonporous film.
  • not only a thin nonporous film but also a thick nonporous film tends to stick to the palate or other portions of the mucous membrane in the oral cavity due to its nonporous smooth surface and extended decomposition. This is because the surface of polymer layers is dissolved into a sticky film.
  • the dissolvable nano web porous film of the invention can be formed in a variety of thickness as necessary. Accordingly, unlike the conventional nonporous film, the nonporous film of the invention is not only prevented from sticking to the surface of the oral cavity, but also rapidly delivers materials due to its wide specific surface area when applied to the mucous membrane of the oral cavity. Thus, the nonporous film has improved discharging effect to discharge medicines fast, and has excellent solubility and dissolvability. Mode for the Invention
  • the polymer solution prepared at process (1) was stored in a syringe, and supplied to an inlet pipe by a syringe pump at a constant speed of 45 ⁇ Jllh.
  • the solution in a liquid phase was pushed out through a minute opening (an inner diameter of 0.2 mm) of a nozzle tip in a spinning unit via the inlet pipe.
  • nano fibers were stacked and wound on the surface of a collector disposed at a predetermined distance while the solvent is volatized or congealed, forming a nano web having a three-dimensional network structure.
  • the nano web of the three-dimensional network structure was compressed at a pressure of 2 atm to form a film having a two-dimensional plate structure.
  • the nano web was compressed to form a nano web porous film having a thickness of 10-50 ⁇ m.
  • the nano web porous film formed at process (2)-l was dried by air heated to about 80-11O 0 C for one minute to adjust its moisture content to 5 ⁇ 20wt%.
  • the nano web porous film dried at process (4) was kept in a thermo-hygrostat at a temperature of 25 0 C and a relative humidity of 45% for 24 hours to be stabilized. Then, the nano web porous film had a moisture content of about 1 l ⁇ 13wt%.
  • the dissolvable nano web porous film was cut into pieces 2 cm wide by 3 cm long. With a piece as a sample, the nano web porous film of 10-50 ⁇ m in thickness was evaluated with respect to its film forming properties and dissolvability. The film forming properties and dissolvability were evaluated by the following method.
  • the sample film was examined using an electron microscope to obtain its forming state, size of the nano fiber, network structure, etc. Results are shown in Figs. 2 to 5.
  • the specific surface area of the dissolvable nano web porous film was measured by the BET (Brunauer, Emmett, Teller) method.
  • the nano fiber had a diameter of about 200 nm
  • the porous film had a specific surface area of 110 mVg and porosity of 42%.
  • the sample film was put in tepid water at 35 0 C, and left after being shaken two or three times. Here, the container was carefully shaken such that the film was not stuck on the wall of the container. Then, the dissolvability of the film was evaluated by measuring time taken for complete dissolution of the film.
  • the dissolvability of the film in the oral cavity was determined by putting the sample film in the mouth of an adult male and measuring time taken for complete dissolution of the film by saliva. Results of the dissolvability in tepid water and in the oral cavity are shown in Fig. 8.
  • the porous film having a thickness of 20 ⁇ m in this example was completely dissolved within 7 seconds in tepid water and within 8 seconds in the oral cavity.
  • the solution was kept for 6 hours or more to remove air bubbles. Then, the solution was coated to a thin film and cast to produce a film having a thickness in the range of 10-50/M.
  • the resulting nonporous film was dried by heated air at about 60- 100 0 C and kept in a thermo-hygrostat at a temperature of 25 0 C and a relative humidity of 45% for 24 hours to be stabilized.
  • the nonporous film had a moisture content of about 1 l ⁇ 13wt%.
  • the nonporous film was cut into pieces 2 cm wide by 3 cm long.
  • the nonporous film produced in this example was evaluated by the same method as in Example 1 with respect to film forming properties and dissolvability (evaluation of surface-active reaction of nonporous film).
  • a film-forming state of the film was observed by an electron microscope, of which results are shown in Figs. 6 and 7.
  • Results of the dissolvability in tepid water and in the oral cavity are shown in Fig. 8.
  • the nonporous film having a thickness of 20 ⁇ m was completely dissolved within 33 seconds in tepid water and within 35 seconds in the oral cavity.
  • sucrose fatty acid ester was added to 71.41wt% distilled water, and sufficiently uniformly dispersed at room temperature. Then, 0.3wt% sorbitol, 0.9wt% propylene glycol and 0.4wt% glycerine were added to the resulting solution, and heated to 7O 0 C. 23wt% hydroxypropylmethyl cellulose (HPMC) was slowly added to the heated solution, and stirred to be completely dissolved in the solution.
  • HPMC hydroxypropylmethyl cellulose
  • Example 4 After heating 77wt% distilled water to 7O 0 C, 21wt% pectin, 0.5wt% carrageenan,
  • solutions were prepared using ingredients and content shown in Table 1 by the following process. Avicel was added to distilled water (DW), and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, sucrose fatty acid ester was added to the solution, and completely dissolved therein. (In Examples 10, 16 and 22 where avicel was not used, sucrose fatty acid ester was added to distilled water, and sufficiently dissolved at room temperature for about 10 minutes.) Then, sorbitol, propylene glycol, and glycerine were added to the resulting solution and heated to 7O 0 C. Pullulan, pectin, and hydroxypropylmethyl cellulose (HPMC) were slowly added to the heated solution, and stirred to be completely dissolved in the solution.
  • HPMC hydroxypropylmethyl cellulose
  • Examples 41 to 4% solutions were prepared using ingredients shown in Table 3 by the following process. Sucrose fatty acid ester was added to distilled water heated to 5O 0 C, and completely dissolved. Then, propylene glycol and glycerine were added to the resulting solution, and slowly heated to 7O 0 C. Pullulan was slowly added to the heated solution, stirred to be completely dissolved in the solution. After heating the resulting solution to 8O 0 C, carrageenan, locust bean gum (LBG), and xanthan gum were added to the heated resulting solution, and completely dispersed and dissolved.
  • LBG locust bean gum
  • xanthan gum were added to the heated resulting solution, and completely dispersed and dissolved.
  • a pharmaceutical active agent e.g., dextromethorphan HBr in Example 41, phenylephrine HCl in Example 42, alkylamines chloropheniramine in Example 43, loperamide HCl in Example 44, Nicotine for Example 45, magnesium stearate in Example 46, oxybutynin in Example 47, and extradiol in Example 48
  • the solution was stirred until all ingredients were uniformly dispersed and completely dissolved, thereby preparing a polymer solution.
  • a nano web porous film was produced using the solution by the same method as in Example 1, and cut in pieces of a suitable size capable of ensuring a suitable pharmaceutical content, thereby preparing a pharmaceutical nano web porous film.
  • solutions were prepared using ingredients in Table 4 by the following process. Avicel was added to distilled water (DW), and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, sucrose fatty acid ester and polysorbate 80 were added to the solution, and completely dissolved therein. Then, sorbitol, propylene glycol, and glycerine were added to the resulting solution and heated to 7O 0 C. Pullulan, pectin and hydroxypropylmethyl cellulose (HPMC) were slowly added to the heated solution, and stirred to be completely dissolved in the solution.
  • DW distilled water
  • HPMC hydroxypropylmethyl cellulose
  • Examples 67 to 72 solutions were prepared using ingredients shown in Table 5 by the following process. Avicel was added to distilled water (DW), and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, sucrose fatty acid ester and polysorbate 80 were added to the solution, and completely dissolved therein. Then, sorbitol, propylene glycol, and glycerine were added to the resulting solution and heated to 7O 0 C. Pullulan was slowly added to the heated solution, and stirred to be completely dissolved in the solution. After heating the resulting solution to 8O 0 C, carrageenan, locust bean gum (LBG), xanthan gum and guar gum are added thereto, and completely dispersed and dissolved.
  • LBG locust bean gum
  • xanthan gum and guar gum are added thereto, and completely dispersed and dissolved.

Abstract

A dissolvable nano web porous film has a network structure and a large specific surface area. The network structure is formed by stacking nano fibers that have a thickness of 10∼50,000 nm. The nano fibers are formed of a composition comprising a nano fiber forming polymer, a gelling agent, a plasticizer, an optional active component and an optional additive. A method of preparing a dissolvable nano web film comprises producing a polymer melt or solution formed of a composition that comprises a nano fiber forming polymer, a gelling agent, a plasticizer, an optional active component and additives, spinning the melt or solution to form a nano web porous film having nano webs stacked in a network structure, drying the nano web porous film, and stabilizing the nano web porous film. The porous film has a 5∼5000 times higher specific surface area and a 2∼20 times faster dissolving time than a conventional film. The dissolvable nano web porous film has excellent dissolvability and solubility.

Description

Description
DISSOLVABLE NANO WEB POROUS FILM AND METHOD OF PREPARING THE SAME
Technical Field
[1] The present invention relates to a dissolvable nano web porous film that is biologically or physiologically applicable, and a method of preparing the same. More particularly, the present invention relates to a nano web porous film that has a nano web network structure and a large specific surface area and a method of preparing the same.
[2]
Background Art
[3] Generally, conventional edible nonporous films are produced in such a fashion of: dissolving polymers such as starch, pullulan, etc., and materials which include film forming agents, plasticizer, flavoring agents, sulfur precipitating agents, saliva stimulating agents, cooling agents, surfactants, stabilizing agents, emulsifying agents, thickening agents, binding agents, coloring agents, pigments, sweeteners, fragrances, antimicrobial agents, etc. in a solvent such as water to provide a mixture thereof; forming the mixture into a film, followed by drying the film; cutting the obtained film to pieces of the film having a proper size; and putting them in a container.
[4] The conventional edible nonporous films require excellent dissolvability in a mouth such that the films are easily liquefied in the mouth, and drying resistance whereby the films are not cracked or curled. Further, the films should not become sticky due to absorption of moisture or heat.
[5] Industrially, natural starch is used as a main ingredient for producing a food packaging film. However, as the starch has high viscosity, it is necessary to decrease the concentration of starch to form an edible thin nonporous film.
[6] Such a thin nonporous film tends to absorb moisture, which causes sticking of the film. In the case of containing protein such as gelatin as a main ingredient, the film tends to absorb moisture or tends to be dissolved at high temperature and humidity, and thus it can easily become sticky in the summer.
[7] JP Patent Publication No. 1995-100186, JP Patent Publication No. 1993-220203, and
JP Patent Publication No. 1999-116469 disclose a film capable of being quickly dissolved in the mouth. JP Patent Publication No. 1993-236885 discloses an edible film as a vehicle to carry flavoring and refreshing food without attracting public attention, and a film that contains pullulan and carrageenan to improve drying resistance. However, these films have low resistance to moisture and suffer from sticking in highly humid conditions.
[8] US Patent No. 3,784,390 discloses pullulan films and their use in coating and packing materials for foods, pharmaceuticals and other oxygen sensitive materials. US Patent No. 4,623,394 discloses a method of preparing a film with pullulan. US Patent No. 7,067,116 discloses products of edible films which include pullulan binders, polysaccharides, antibacterial agents, flavor-imparting agents, and pharmaceutically active components.
[9] US Patent No. 6,528,088 discloses a film that contains modified starch, such as etherified starch or esterified starch, and plasticizers mixed with the starch in the ratio of at least 0.5: 1 by weight to increase the plasticity of the film. However, a high plasticizer content of the film causes an unpleasant feeling in the mouth and insufficient sticking resistance.
[10] US Patent No. 6,656,493 discloses a film that contains sodium alginate and mal- todextrin. Maltodextrin having a low molecular weight is added to the films to improve dissolution in the oral cavity. However, as the concentration of maltodextrin increases, moisture resistance of the film decreases, causing easy sticking thereof. The drying resistance of the films is also not satisfactory.
[11] US Patent Application Publication No. 2003/0099692 discloses a film that includes processed starch as a main ingredient. For the thin film, the starch is cross-linked and chemically processed as in acetyl, ester, hydroxyethyl and hydroxyproply derivatives of starch. Further, derivatives of starch by oxidation, enzyme conversion, acid hydrolysis, etc. may also be used in forming the film. The processed starch is substantially independently used, and thus the film does not have sufficient sticking resistance.
[12] Conventional methods relating to administration of a pharmaceutical active agent in an edible film vehicle are disclosed in the following documents: WO 98/26763 discloses a film for use in the oral cavity, which may contain a cosmetic or pharmaceutical active component; WO 01/70194 discloses a rapidly dissolvable edible film that contains an ion exchange resin as a taste masking agent; WO 98/20862 also discloses a film for use in the oral cavity, which may contain a cosmetic or pharmaceutical active component; WO 99/17753 discloses a rapidly soluble film for delivering medical supplies to be absorbed in a digestive tract; and US Patent No. 6,596,290 discloses the delivery of pharmaceutical agents in an edible film vehicle.
[13] Meanwhile, there are methods including spun-lacing, spun-bonding, melt-blown, flash spinning, electro spinning, etc. to successively produce webs directly from a polymer solution. Since these methods are applicable to a variety of polymers and can produce polymer webs instantly in a liquid condition, the polymer webs can be formed by these very simplified processes as compared to conventional spinning methods. Recently, these techniques are applied to formation of an electrolyte layer, an isolation layer, a filter, a dressing web, a barrier web, a scaffolder, a sensor web, etc. based on a polymer web of minute and superfine fibers.
[14] US Patent No. 5,935,883 discloses a process of producing a superfine microfiber split web using a melt-blown device. US Patent No. 6,057,256 discloses formation of a coherent entangled web by blowing a polymer solution in a collector. US Patent No. 6,106,913 discloses a web produced with a fiber of 1 nm using the combination of an electro spinning method and an air vortex spinning method. US Patent No. 6,110,509 discloses a biodegradable silk web having a diameter ranging from 2 to 2000 nm using an electro spinning method.
[15] KR patent publication No. 2001-0031586 discloses a process of massively preparing a nano-sized nanofiber web by organically combining a melt-blown method and an electrostatic spinning method. KR patent publication No. 2001-0031587 discloses a process of preparing a nanofiber web by organically combining a flash spinning method and an electrostatic spinning method. KR patent publications Nos. 2003-0077384 and 2004-0040692 disclose a method of producing a superfine nanofiber web which is improved in productivity and yield by combination of the melt-blown spinning method and the electrostatic spinning method.
[16] As described above, a variety of patents and applications disclose the method of preparing the edible nonporous film. However, there is still a need for an edible web porous film having excellent dissolvability, drying resistance, and sticking resistance, and such a need can be satisfied by the present invention that provides an edible web porous film having a nano-network structure, as described below.
[17]
Disclosure of Invention Technical Problem
[18] The present invention has been made to solve the foregoing problems of the prior art and therefore an aspect of the present invention is to provide a dissolvable nano web porous film that is biologically and physiologically applicable.
[19] Another aspect of the invention is to provide a dissolvable nano web porous film that is quickly dissolved in saliva in administration into the oval cavity or fluid secreted from the skin.
[20] A further aspect of the present invention is to provide an edible nano web porous film, of which active component is absorbed into the body and which is edible without water.
[21] Yet another aspect of the present invention is to provide a nano web porous film that has superior dissolvability, drying resistance, and sticking resistance.
[22] Yet another aspect of the present invention is to provide a dissolvable nano web porous film where an active component and the film are capable of being rapidly decomposed or dissolved.
[23] Yet another aspect of the present invention is to provide a method of preparing a dissolvable nano web porous film having the foregoing properties. Technical Solution
[24] According to an aspect of the invention, the present invention provides a dissolvable nano web porous film having a network structure, wherein the network structure is formed by stacking nano fibers, the nano fibers having a thickness of 10-50,000 nm and formed of a composition composed of (A) a nano fiber forming polymer, (B) a gelling agent, and (C) a plasticizer.
[25] According to another aspect of the invention, the present invention provides a method of preparing a dissolvable nano web film, comprising: (1) forming a polymer melt or solution of a composition composed of (A) a nano fiber forming polymer, (B) a gelling agent and (C) a plasticizer, as essential ingredients, and (D) active components, and (E) aάϊtives, as optional ingredients; (2) spinning the melt or solution to form a nano web porous film having nano webs stacked in a three-dimensional network structure; (3) drying the nano web porous film; and (4) stabilizing the nano web porous film.
[26]
Advantageous Effects
[27] As set forth above, according to the present invention, the dissolvable nano web porous film has a 5-5000 times lager specific surface area and a 2-20 times faster dissolving time than a conventional film. Thus, the dissolvable nano web porous film is excellent in dissolvability and solubility.
[28] According to the present invention, the dissolvable nano porous film is used for a medicine to be edible without water. In this case, since the film is rapidly dissolvable and liquefied by saliva in the oral cavity, the medicine is absorbed into the bloodstream through a mucous membrane in the oral cavity without any displeasure. As such, since the medicine is absorbed into the bloodstream without passing through the stomach and gullet, it is advantageous in rapidly providing therapeutic effects.
[29] The dissolvable nano porous film according to the present invention can be preferably used as a carrier for functional foods, drugs, plant extracts, etc. which have a very small quantity of effective ingredients.
[30] According to the present invention, the dissolvable nano web porous film is provided along with emulsified fat- soluble flavors and emulsified oils and fats to be used as a mouth-freshening nano web porous film or a flavor nano web porous film for bad breath prevention, refreshment, improvement of edibility, nutrients supplementation, drug delivery, improvement of health, etc. As a result, these films can be a substitute for gum, candies, a spray type oral cleansing agent, a breath freshening agent, and the like.
[31] According to the present invention, since the dissolvable nano web porous film is dissolved by fluid secreted from the skin or moisture to be rapidly soluble and liquefied, medicines or functional materials are absorbed epidermally and percu- taneously without displeasure. Accordingly, therapeutic effects are quickly exhibited, and thus the film can be useful for skin care, therapy for skin, etc.
[32] According to the present invention, the dissolvable nano web porous film is provided along with a bleaching agent or a dental bleaching agent to be used as a dental bleaching film. Brief Description of the Drawings
[33] The above and other aspects, features and other advantages of the present invention will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
[34] Fig. 1 is a mimetic diagram of a portion of a network structure on the surface of a dissolvable nano web porous film according to an exemplary embodiment of the present invention, in which reference numeral 1 indicates a cross section of a nano fiber in the dissolvable nano web porous film, and reference numeral 2 indicates a pore between the nano fibers;
[35] Fig. 2 is a micrograph of the surface of the nano web porous film taken by a scanning electron microscope (SEM) according to a first exemplary embodiment of the present invention, illustrating that plural nano fibers are stacked to form a nano web where a network structure and pores exist; [36] Fig. 3 is an enlarged SEM image of a portion of the surface of the dissolvable nano web porous film according to the first exemplary embodiment of the present invention;
[37] Fig. 4 is a highly enlarged SEM image of a portion of the surface of the dissolvable nano web porous film according to the first exemplary embodiment of the present invention;
[38] Fig. 5 is an SEM image of the cross section of the dissolvable nano web porous film according to the first exemplary embodiment of the present invention;
[39] Fig. 6 is an SEM image of the surface of a nonporous film according to a second exemplary embodiment of the present invention;
[40] Fig. 7 is an SEM image of the cross section of the nonporous film according to the second exemplary embodiment of the present invention; and
[41] Fig. 8 is a graph illustrating the relation (i.e., dissolvability in tepid water and in the oral cavity) between the dissolving time and the thickness of the dissolvable nano web porous film according to the first exemplary embodiment of the present invention and the relation between the dissolving time and the thickness of the nonporous film according to the second exemplary embodiment of the present invention.
[42]
Best Mode for Carrying Out the Invention
[43] Exemplary embodiments of the present invention will now be described in detail with reference to the accompanying drawings.
[44] The present invention relates to a dissolvable nano web porous film that can be rapidly dissolved by saliva in the oral cavity or fluid secreted from the skin, and a method of preparing the same. Unlike a conventional nonporous film, the nano web porous film has a large surface area, pores and a rapidly soluble network structure capable of rapidly responding to materials from the outside, and is rapidly dissolved by the saliva in the oral cavity or the fluid secreted from the skin. Due to the film's rapid dissolvability, active components (e.g., drugs and the like) in the film can be more effectively absorbed into the body. Also, the film has edibility to allow the film to be edible without water and without any displeasure in a dissolved state, dissolvability, drying resistance, and sticking resistance.
[45] The dissolvable nano web porous film according to the exemplary embodiment of the present invention has a network structure where nano fibers having a thickness of 10-50,000 nm are stacked. Here, the nano fibers are formed of a composition composed of (A) a nano fiber forming polymer, (B) a gelling agent, and (C) a plasticizer. If the nano fiber has a thickness less than 10 nm, it is difficult to me- chanically produce the film. If the nano fiber has a thickness more than 50,000 nm, the film has reduced dissolvability.
[46] The nano web porous film is preferably formed to have a thickness of 5-500 μm to obtain excellent properties in view of drying resistance, feeling in the oral cavity, dissolvability in the oral cavity, etc. The nano web porous film preferably has porosity ranging from 10-90%. If the porosity is less than 10%, it is difficult to mechanically produce the film. If the porosity is more than 90%, it is difficult to form a nano web. The nano web porous film preferably has a specific surface area in the range of 1-1,000 mVg. If the specific surface area is less than 1 mVg, the film may not exhibit excellent dissolvability. If the specific surface area is more than 1,000 mVg, it is difficult to mechanically produce the film.
[47] Hereinafter, a composition and a method for forming the film according to the present invention will be described in detail.
[48]
[49] 1. Composition for nano web porous film
[50] According to the present invention, the dissolvable nano web porous film
(hereinafter, also referred to as a "porous film") is formed of nano fibers having a composition that essentially consist of (A) a nano fiber forming polymer, (B) a gelling agent, and (C) a plasticizer. Optionally, the composition, which forms the nano fiber, may further comprise (D) an active component andhr (E) other aάϊtives according to use of the porous film, if necessary.
[51] (A) Nano fiber forming polymer
[52] According to the present invention, the nano fiber forming polymer (A), an ingredient of the composition for forming the (dissolvable and/όr edible) nano web porous film, is a main ingredient for the nano fiber and the nano web porous film, and carries active components in a nano web.
[53] Examples of the nano fiber forming polymer (A) used to form the film of the invention include, but are not limited to, pullulan, hjdroxypropylmethyl cellulose (HPMC), hylroxymethyl cellulose (HMC), hylroxyethyl cellulose (HEC), hy- droxypropyl cellulose (HPC), ethyl cellulose (EC), methyl cellulose (MC), hjdrox- ypropylmethyl cellulose phthalate (HPMCP), hyiroxypropylmethyl cellulose acetate succinate (HPMCAS), cellulose acetate phthalate (CAP), carboxymethyl cellulose (CMC), polyvinyl pyrrolidone (PVP), polyvinyl alcohol (PVA), sodium alginate, polyethylene glycol, locust bean gum, xanthan gum, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methyl methacrylate copolymer, amylose, dextrin, chitin, chitosan, levan, elsinan, collagen, gelatin, glucan, high amylose starch (corn starch, potato starch, wheat starch, rice starch, mung-bean starch, yellow bean starch, etc.), ester derivatives of starch, soy protein isolate, whey protein isolate, casein, gellan, pectin, and a combination thereof. Also, a mixture of two or more aforementioned materials may be used as the nano fiber forming polymer (A). The nano fiber forming polymer (A) has an average molecular weight of 1,000-2,000,000 g/mol. If the average molecular weight is less than 1,000 g/mol, the viscosity of the polymer is low, making it difficult to form a nano web. If the average molecular weight is more than 2,000,000 g/mol, the viscosity is high, making it difficult to process the polymer. In addition to the aforementioned polymers, any of known hydrophilic natural polymers having an average molecular weight of 1,000-2,000,000 g/mol may be used to form the film of the invention.
[54] The nano fiber forming polymer (A) is added in an amount of l~99wt%, and preferably, of about 15~80wt%, to the composition of the nano web porous film. If the polymer content is less than lwt%, it is difficult to form a fiber. And, since other solvents or ingredients should also be mixed in formation of the nano fiber, the polymer content may be added up to 99wt%.
[55] The other ingredients (specifically, the gelling agent, plasticizer, active ingredients, additives, and water) of the composition are added to the composition according to proposed contents and conditions, which will be described below.
[56]
[57] (B) Gelling agent
[58] The gelling agent, an ingredient of the composition to form the dissolvable nano web porous film, is used to prevent the nano web porous film from breaking, and becomes gel when cooled. Examples of the gelling agent include, but are not limited to, a natural gelling agent, such as locust bean gum, xanthan gum, carrageenan, gelatin, gellan gum, agar, alginates, guar gum, starch, pectin, ethyl cellulose, methyl cellulose, sodium carboxymethyl cellulose, polyethylene glycol, and combinations thereof. Also, a mixture of two or more aforementioned materials may be used as the gelling agent.
[59] A mixing ratio of the gelling agent (B) to 100wt% polymer (A) is in the range of about 0.1~50wt% (for example, 0.1-50 parts by weight gelling agent to 100 parts by weight polymer), and preferably, of 0.4~30wt%. If the mixing ratio is below the range, the film tends to be curled. Conversely, if the ratio exceeds the range, the film has low dissolvability.
[60] [61] (C) Plasticizer
[62] The plasticizer is used to endow the film with properties of hardening prevention, sticking prevention, and plasticity. The plasticizer also drops the glass transition temperature of the film during the process, thereby adjusting the melting viscosity thereof. Examples of the plasticizer includes, but are not limited to, sorbitol, mannitol, glycerin, propylene glycol, polyethylene glycol, fatty acid glycerol monoester, sugar alcohol, monosaccharide, oligosaccharide, Methylene glycol, myvacet, triethyl citrate, triacetin, propylene glycol monocaprylate, propylene glycol dicaprylate, miglyol, etc., all of which are organic compounds of polyol containing at least one hjdroxyl group. Further, alcohol-based or polyol-based organic compounds induing at least one hjdroxyl group may be used as the plasticizer. These materials are used independently or together. A mixture of two or more aforementioned materials may be used as the plasticizer. A mixing ratio of the plasticizer (C) to 100wt% polymer (A) is in the range of about 0.1~40wt% (for example, about 0.1- 40 parts by weight plasticizer to 100 parts by weight polymer). If the mixing ratio is below the range, the film deteriorates in drying resistance. If the ratio is above the range, the film deteriorates in sticking resistance.
[63]
[64] (D) Active components
[65] Pursuant to use of the dissolvable nano web porous film, the composition may further comprise an active component as necessary. The active component comprises food, medicines, drugs, functional materials, etc., which promote structural and functional modifications in the body to which it is administered.
[66] The active component is not specifically limited, but provided as any of materials which are physiologically applicable, mixable with other materials of the nano web porous film, and have activity corresponding to uses of the film. Examples of the active component include, but are not limited to, one selected from the group or type consisting of: α-adrenergic agonists; β-adrenergic agonists; α-adrenergic blocking agents; β-adrenergic blocking agents; alcohol prohibition agents; aldose-reductase inhibitors; anabolic agents; narcotic analgesics; derivatives of morphine; non-narcotic analgesics, preferably, salicylates and derivatives thereof; androgens; anesthetics; appetite inhibitors; anthelmintics (taenia, nematode, filarial, schistosome, and fluke eliminating active agents); antiacne agents; antiallergic agents; antiamebic drugs (ameba eliminating agents); antiandrogens; angina therapeutic agents; antiarrhythmic drugs; antiarteriosclerotic agents; antiarthritic and antirheumatic agents; antimicrobial agents (antibiotics), preferably, aminoglycosides, amphenicols, ansamycins, β-lactams (particularly, carbapenems, cephalosporins, cephamycins, monolactams, oxacephems, and penicillins), lincosamides, macrolides, polypeptides and tetracyclines; synthetic antimicrobials, preferably, 2,4-diaminopyrimidines, nitrofurans, quinolones and quinolone analogues, sulfonamides and sulfones; anticholinergics; anticonvulsants; antidepressants, preferably, bicyclic antidepressants, hyirazides, hydrazines, pyrrolidones, tetracycline antidepressants; tricyclic antidepressants, polycyclic imides; antidiabetic agents, preferably, biguanides, sulfonylurea derivatives; antidiarrheals; antidiuretic agents; antiestrogens; antifungal agents/ fungicides, preferably, polyenes; synthetic antifungal agent/ fungicide, preferably, allyl amines, imidazoles, triazoles; antiglaucomatous agents; antigonado-trophins; antigput agents; antihistamines, preferably, alkylamine derivatives, aminoalkyl ethers, ethylenediamine derivatives, piperazines, tricyclic compounds (particularly, phenothiazines); anti- hyperlipoproteinemia agents (fat inhibitors), preferably, aryloxy alkane acid derivatives (particularly, clofibric acid derivatives and analogues), bile acid-masking materials, HMG-Co A-reductase inhibitors, nicotinic acid derivatives, thyroid hormones and analogues thereof; antihypertensive drugs/hypotensives, preferably, benzothiadiazine derivatives, N-carboxylalkyl-(peptide/lactam) derivatives, guanidine derivatives, hydrazines/ phthalazines, imidazole derivatives, quaternary ammonium compounds, quinazoline derivatives, reserpine derivatives, sulfonamide derivatives; antihyperthyroid agents; antihypotensive agents; antihypothyroid agent; non-steroidal antiinflammatory drugs (antiphlogistics), preferably, aminoarylcarboxyl acid, arylacetic acid, arylbutyric acid, arylcaboxylic acid and arylpropionic acid derivatives, pyrazoles, pyrazolones, salicylic acid derivatives, thiazine carboxamide; antimalarial drugs, preferably, quinines, salts thereof, acids thereof and derivatives thereof; antimigraine drugs; retching inhibitors; antineoplastic drugs, preferably, alkylating drugs (particularly, alkyl sulfonates, aziridines, ethylenimines, methyl melamines, nitrogen mustard gases, and nitrosoureas); antibiotics, antimetabolic agents (particularly, folinic acid analogues, purine analogues and pyrimidine analogues), enzymes, interferons, in- terleukins; hormonal antineoplastics, preferably, androgens, antiadrenalines, an- tiandrogens, antiestrogens (particularly, aromatase inhibitors); antineoplastic food additives; antiparkinsonian agents; antipheochromocytoma agents; antipneumocystis agents; prostatic hypertrophy therapeutic agents; protozoacides, preferably, an- tileishmania, antitrichomonal and anti-trypanosoma drugs; antipruriginous agents; an- tipsoriasis drugs; antineuroleptic agents, preferably, butyrophenones, phenothiazines, thioxanthenes, tricyclic drugs, 4-arylpiperazines, 4-arylpiperidines; antipyretics; antir- ickettsia agents; antiseborrheic agents; antiseptics, preferably, guanidines, halogens and halogen compounds, nitrofuran, phenols, quinolines; antiseizur drugs, anti- con vulsants/convulsion inhibitors; antithrombotics; antitussives; antiulcer drugs; uric acid eliminating agents (antiurolithiasis agents); antiophidicas; antiviral drugs, preferably, purines, pyrimidinones; anxiolytic, preferably, arylpiperazines, benzodiazepine derivatives, carbamates; benzodiazepine antagonists; bronchodilators, preferably, ephedrine derivatives, quaternary ammonium compounds, xanthine derivatives; calcium channel blockers, preferably, arylalkylamines, dihjdropyridine derivatives, piperazine derivatives; calcium modulators; cardiac stimulants; chelate or complex forming agents; cholecystokinin antagonists; antigallstone agents; bile sec- retagpgues; parasympathomimetic drugs; cholinesterase inhibitors; cholinesterase rehabilitation materials; CNS stimulants; decongestants; tooth decay prevention agents; decolorants; diuretics, preferably, organomercury compounds, pteridines, purines, steroids, sulfonamides, uracils; dopamine receptor agonists; ectoparasite eliminating agents; enzymes, preferably, digestive enzymes, penicillin inactivating enzymes, proteolytic enzymes; enzyme inducers; steroidal and non-steroidal estrogens; gastric acid secretion inhibitors; glucocorticoids; gonadotropic activators; gonadotropin hormones; growth hormone inhibitors; growth hormone releasing factors; growth stimulants; anticoagulants; heparin antagonists; liver protective agents; liver disease therapeutic agents; immune modulators; immune inhibitors; ion exchange resins; prolactins; LH-RH agonists; lipotropic agents; lupus erythematosus eliminating agents; mineralocorticoids; miotic agents; monoamine oxidase inhibitors; mucolytic agents; muscle relaxants; narcotic antagonists; neuroprotective agents; nootropics; ophthalmic agents; ovarian hormones; oxytocic agents; pepsin inhibitors; peristaltic stimulants; progestogens; prolactin inhibitors; prostaglandins and analogues thereof; protease inhibitors; respiratory stimulants; hardening agents; sedatives/ somnifacients, preferably, non-cyclic ureides, alcohols, amides, barbiturates acid derivatives, benzodiazepine derivatives, bromides, carbamates, chloral derivatives, piperidinediones, quinazolone derivatives; antithrombotic agents; thyroid hormones; uricosuric agents ; vasodilators (cerebrum); vasodilators (coronary arteries); vasodilators (peripheral nerve); blood vessel protective agents; vitamins, provitamins, vitamin extracts, vitamin derivatives; and trauma therapeutic agents.
[67] The active component is an optional ingredient and selectively added according to purposes of the nano web porous film. The active component is not limited to the aforementioned materials, but may employ drugs which can be pharmaceutically activated. The active component is not specifically limited to a certain component, so long as it is capable of being dissolved in water or ethanol. A proper dosage of the active component is 0.001-50 mg.
[68] According to the present invention, the dissolvable nano web porous film is edible without water, and rapidly dissolved and liquefied by saliva in the oral cavity, so that drugs may be absorbed into the body without any displeasure. Even in this case, it is desirable to use an active component (drugs and the like) which does not have ill-affect on digestive organs, the mucous membrane in the oral cavity, and the like. The active component is optionally provided up to 40wt%, and preferably, 0.01~40wt%, with respect to the total weight of the final film. Since it is an optional component, the active component does not have any lower limit in content, but can be added in a content of 0.01wt% or more with respect to the final film so as to exhibit its properties by the addition. If the content of the active component exceeds 40wt%, it is difficult to form a nano web.
[69]
[70] (E) Other Additives
[71] If necessary, additives may be optionally added to the composition for the dissolvable nano web porous film to improve properties required for the film. Examples of the additives include, but are not limited to, flavoring agents, sulfur precipitating agents, saliva stimulating agents, cooling agents, surfactants, stabilizing agents, emulsifying agents, thickening agents, binding agents, coloring agents, pigments, sweeteners, fragrances, germicides, antimicrobial agents, pharmaceutical active agents, etc.
[72] In more detail, the additives may be provided as, but are not limited to, saccharides to improve taste (all typical saccharides, for example, but not limited to, white sucrose, maltose, fructose, galactooligosaccharide, galactose, fructooligosaccharide, dextrin, ion starch syrup, malt syrup, lactose, glucose, sorbitol, mannitol, xylitol, inositol, etc.); saliva stimulating agents (e.g., but not limited to, citric, lactic, maleic, succinic, ascorbic, adipic, fumaric, and tartaric acids); sweeteners (e.g., but not limited to, monosaccharide, disaccharide, ribose, glucose, mannose, galactose, fructose, sucrose, maltose, invert sugars, corn syrup solids, glythyl retinoate, white sugars, water soluble artificial sweeteners); thickening agents (e.g., but not limited to, methyl cellulose, carboxyl methyl cellulose, etc.); masking agents (e.g., but not limited to, citric, tartaric, and fumaric acids); dyes and coloring agents (e.g., but not limited to, natural pigments, tar pigments, etc.); flavoring and refreshing agents (e.g., but not limited to, refreshing agent such as menthol, peppermint oil, peppermint and spearmint, natural or synthetic fragrances, etc.), nutrient, plant extracts, herbal components, vitamins, minerals, nitroglycerin, catechin, polyphenols, enzymes, emulsifiers, seasonings, fragrances, fats, and oil; when applied onto a skin adenosine, coenzyme QlO, vitamin E, vitamin C, fibroin, amyloglucosidase, albutin, hyaluronic acid, D/DL-panthenol, neomycin, hydrocortisone acetate, etc. These materials may be used independently or together. Also, a mixture of two or more aforementioned materials may be used as the additive.
[73] The additives are provided up to 40wt%, and preferably, in the range of
0.01~40wt%, to the total weight of the final film. The additives do not have a lower limit in content, but should be added in a content of 0.01wt% or more with respect to the final film so as to exhibit its properties by the addition. If the content of additives exceeds 40wt%, it is difficult to form a nano web.
[74] The composition is melted or dissolved to form a polymer melt or polymer solution.
Then, the polymer melt or solution is spun into nano fibers, and the fibers are stacked, thereby producing a nano web porous film in a network structure according to the present invention. Hereinafter, the method of preparing the nano web porous film according to the present invention will be described in detail.
[75]
[76] 2. Method of preparing nano web porous film
[77] (1) Preparation of polymer melt or polymer solution
[78] A composition, which comprises (A) a nano fiber forming polymer, (B) a gelling agent, and (C) a plasticizer, as essential ingredients, and (D) an active component and/ or (E) additives, as optional ingredients, is melted or dissolved to prepare a polymer melt or polymer solution. Here, (A) to (E) ingredients may be added regardless of order, which is adjusted by those skilled in the art in consideration of properties and characteristics thereof. A single or two or more ingredients may be melted or dissolved according to proper selection by those skilled in the art in consideration of the properties and characteristic thereof.
[79] For example, but not limited to, a polymer solution can be produced by the following process: dissolving or dispersing (A) a nano web film forming polymer in a solvent in an amount of about 1.5-4.5 times the total amount of the polymer at room temperature or a certain temperature, adding (B) a gelling agent and (C) a plasticizer thereto, followed by dissolving them, and dissolving and dispersing (D) an active component and (E) additives as necessary. Here, water is generally used as a solvent. [80]
[81] (2) Formation of nano web porous film by spinning
[82] The polymer melt or polymer solution is spun into nano fibers. The spinning process is performed by, for example, spun-lace, spun-bond, melt-blown, flash spinning, electro spinning, etc. The nano fibers are formed in the form of non- woven fabrics by spinning the polymer melt or polymer solution. By stacking the nano fibers in the form of the non- woven fabrics on a base or winding the nano fibers around a drum, a nano web is produced in a network structure where a great number of nano fibers are stacked. Here, the nano fibers are stacked or wound evenly such that the nano web has a uniform overall thickness. As a result, the nano web having the network structure where the plural nano fibers are stacked or wound evenly can be used as a porous film of the present invention.
[83] In spinning, for example, but not being limited to, a solid content of the polymer melt or polymer solution is preferably adjusted to a concentration of about 15~50wt%. If the solid content is less than 15wt%, it is difficult to form a nano web due to low viscosity. If the solid content is more than 50wt%, it is difficult to form a stream of polymer melt or polymer solution using electric force due to high viscosity.
[84] The spinning process is performed, but is not limited to, as follows. The polymer melt or polymer solution is stored in a syringe, and is pressurized at a constant pressure by means of a syringe pump. Then, the pressurized polymer melt or solution in a liquid phase is pushed out through a minute opening (an inner diameter of 0.1-2 mm) of a nozzle tip in a spinning unit via an inlet pipe. With an electric field of 1-300 kV, and preferably, of 15-35 kV applied, the solvent is volatilized or congeals, and nano fibers are stacked or wound on the surface of a collector (e.g., drum) disposed at a predetermined distance, thereby forming the nano web having the network structure.
[85] In forming the nano web of the network structure by the spinning process, it is possible to regulate the porosity of the nano web, the diameter, size and form of the nano fiber, the thickness of the nano web, etc. by controlling some factors (e.g., the diameter of the nozzle tip, the intensity of electric field, the distance between the nozzle tip and the collector, the discharging speed of the melt/solution, the number of nozzles, the discharging amount of the melt/solution, the spinning time, etc.). The nano web is spun and stacked to have a thickness of about 5-500 μm in order that the dissolvable nano web porous film has excellent drying resistance, feeling in the oral cavity, dissolvability in the oral cavity, and other properties.
[86] According to purposes of the porous film, a network structure nano web of nano fibers, which are formed of different kinds of compositions mixed to exhibit different functions and effects, may be stacked and/όr wound to produce a multilayer film that has a variety of properties.
[87]
[88] (2)-l Compression of The Nano Web Ibrous Film
[89] As described in the process (2), the nano webs formed of the nano fibers and having the network structure are stacked to form the porous film, while being adjusted in thickness, density, and porosity thereof. If the nano webs are formed desired thick and densely, the nano webs themselves may be used as the nano web porous film without compression process. Optionally, the nano webs of the network structure formed at the process (2) are compressed to a desired thickness, if necessary to produce the nano web porous film. The nano web porous film has a thickness of 5-500 μm, and preferably, of about 10-200 μm, to obtain excellent properties relating to drying resistance, feeling in the oral cavity, dis solvability in the oral cavity, etc.
[90]
[91] (3) Drying
[92] To obtain excellent properties relating to drying resistance, feeling in the oral cavity, dis solvability in the oral cavity, etc., the nano web film formed in a film type is dried by hot air at about 80-110 0C so as to have a moisture content of 5~20wt%. If the drying temperature is less than 8O0C, the solvent is not likely to be volatilized, and the film is not dried rapidly. If the temperature is more than 11O0C, the film can be deformed. Also, if the moisture content of the film is less than 5wt%, it can be easily broken, whereas, if the content is more than 20wt%, the film is likely to droop and become sticky.
[93]
[94] (4) Stabilization
[95] The dried nano web porous film is kept in a humidity adjusted space or in a thermo- hygrostat to stabilize the moisture content, and the like. Preferably, the stabilization is performed to allow the nano web porous film to have a moisture content of about 5- 15wt% so as to achieve optimal properties relating to feeling in the oral cavity, preservative performance, etc. If the stabilized final porous film has the content of moisture less than 5wt%, it can be easily broken. If the moisture content of the film is more than 15wt%, it tends to droop, and becomes sticky. The stabilization is preferably performed at a temperature of 20~30°C and a relative humidity of 40-50% for 1 to 48 hours in order to achieve optimal properties of the film. It should be noted that the present invention is not limited to the aforementioned stabilization conditions. For example, the stabilization can be generally performed at a temperature of 250C and a relative humidity of 45% for 24 hours.
[96] Fig. 1 is a mimetic diagram of a portion of the network structure on the surface of the dissolvable nano web porous film according to an exemplary embodiment of the invention. Reference numeral 1 indicates a cross section of a nano fiber in the dissolvable nano web porous film, and reference numeral 2 indicates a pore formed between the nano fibers. As shown in Fig. 1, according to the present invention, since the nano web porous film of the network structure comprises a plurality of nano fibers (1), which have a diameter of several to tens of thousands of nanometers and a plurality of pores (2) formed among the nano fibers, it has very high specific surface area and porosity per weight. Unlike a conventional nonporous film, since the porous film of the invention has the nano web structure which is constituted by the network structure and the pores, the porous film has excellent surface activity and dis- solvability. Thus, when the porous film is taken into the oral cavity or applied to the skin, the active components (drugs and the like), carriers or other additives in the film are rapidly dissolved and/όr melted by saliva in the oral cavity or fluid secreted from the skin, so medicines or other active components can be more quickly discharged in the oral cavity or on the skin. More specifically, the porous film exhibits rapid dissolution with a dissolution time in the range of 1-60 seconds, and excellent dis- solvability, which is twice to twenty times higher than that of the conventional nonporous film.
[97] For example, the dissolvable nano web porous film is decomposed and easily dissolved by reaction with amylase of saliva in the oral cavity. Thus, the dissolvable nano web porous film exhibits excellent dis solvability and rapid dissolution, particularly in the oral cavity.
[98] Furthermore, the edible nano web porous film of the invention may be used as a package or carrier to carry functional foods, vitamins, essential minerals, drugs, etc., which can be taken through the oral cavity. Also, since flavoring agents, refined oil, etc. are added to the porous film when it is formed, the porous film can be used as a flavoring carrier. Thus, the film can be used in new forms for health improvement, such as bad breath prevention, refreshment, improvement of edibility, nutrients supplementation, drug delivery, health food supplement, etc.
[99] Since the dissolvable nano web porous film is produced including active components such as drugs, it can be formed as an edible material, which is edible without water. The porous film exhibits edibility to be rapidly dissolved and liquefied by saliva in the oral cavity, so that medicines can be absorbed in the body without any displeasure. The porous film is excellent in view of dissolvability, drying resistance, and sticking resistance, which are fundamental properties required for a dissolvable film. Further, the porous film is biologically and physiologically applicable. That is, the porous film has a solubility that is physiologically allowable in the skin and mucous membranes such as the oral cavity, the gullet, etc.
[100] On the other hand, the conventional nonporous film should have a certain thickness to perform intended functions, e.g., to load active components. Thus, the thickness of the film must be determined by the properties and amount of the active components to be discharged from the film. Generally, an increase in thickness of the film leads to a decrease in decomposition and dissolution rates of the nonporous film. In particular, not only a thin nonporous film but also a thick nonporous film tends to stick to the palate or other portions of the mucous membrane in the oral cavity due to its nonporous smooth surface and extended decomposition. This is because the surface of polymer layers is dissolved into a sticky film.
[101] However, since it is possible to easily control the diameter (several to tens of thousands of nanometers) of fibers in the web to be formed, the thickness (several to tens of thousands of micrometers) of the nano web, and the size of pores under modified conditions, the dissolvable nano web porous film of the invention can be formed in a variety of thickness as necessary. Accordingly, unlike the conventional nonporous film, the nonporous film of the invention is not only prevented from sticking to the surface of the oral cavity, but also rapidly delivers materials due to its wide specific surface area when applied to the mucous membrane of the oral cavity. Thus, the nonporous film has improved discharging effect to discharge medicines fast, and has excellent solubility and dissolvability. Mode for the Invention
[102] Hereinafter, the dissolvable nano web porous film according to the present invention will be described in detail with reference to the following Examples. It should be un derstood that these examples is provided for illustrative purpose only, and do not limit the present invention.
[103]
[104] Example 1
[105] (1) Preparation of polymer solution for forming nano web porous film
[106] 1.5wt% avicel was added to 70wt% distilled water, and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, 0.6wt% sucrose fatty acid ester was added to the solution, and completely dissolved therein. Then, 0.3wt% sorbitol, 0.8wt% propylene glycol, and 0.4wt% glycerine were added to the resulting solution, and heated to 70 0C, 23wt% pullulan was slowly added to the heated solution, and stirred to be completely dissolved in the solution. After heating the resulting solution to 80 0C, 0.13wt% carrageenan, 0.13wt% locust bean gum (LBG), and 0.13wt% xanthan gum were added to the heated resulting solution, and completely dispersed and dissolved. After cooling the resulting solution to 4O0C, 0.46wt% aspartame, 0.04wt% acesulfame K, 0.3wt% malic acid, 2wt% menthol and 0.21wt% citric acid were sequentially added thereto, followed by stirring them until they were uniformly dispersed and completely dissolved, thereby preparing a polymer solution. The solution had a viscosity of about 7,000-8,000 mPa s(25°C). The solution was kept at room temperature for 6 to 24 hours to remove air bubbles.
[107]
[108] (2) Formation of nano web porous film by electrospinning
[109] The polymer solution prepared at process (1) was stored in a syringe, and supplied to an inlet pipe by a syringe pump at a constant speed of 45 μJllh. The solution in a liquid phase was pushed out through a minute opening (an inner diameter of 0.2 mm) of a nozzle tip in a spinning unit via the inlet pipe. With an electric field of 15 kV applied, nano fibers were stacked and wound on the surface of a collector disposed at a predetermined distance while the solvent is volatized or congealed, forming a nano web having a three-dimensional network structure.
[HO]
[111] (2)- 1 Compression of the nano web porous film
[112] The nano web of the three-dimensional network structure was compressed at a pressure of 2 atm to form a film having a two-dimensional plate structure. In this example, the nano web was compressed to form a nano web porous film having a thickness of 10-50 μm.
[113]
[114] (3) Drying nano web porous film
[115] The nano web porous film formed at process (2)-l was dried by air heated to about 80-11O0C for one minute to adjust its moisture content to 5~20wt%.
[116]
[117] (4) Stabilization of nano web porous film
[118] The nano web porous film dried at process (4) was kept in a thermo-hygrostat at a temperature of 25 0C and a relative humidity of 45% for 24 hours to be stabilized. Then, the nano web porous film had a moisture content of about 1 l~13wt%.
[119] The dissolvable nano web porous film was cut into pieces 2 cm wide by 3 cm long. With a piece as a sample, the nano web porous film of 10-50 μm in thickness was evaluated with respect to its film forming properties and dissolvability. The film forming properties and dissolvability were evaluated by the following method.
[120]
[121] (A) Evaluation of film forming properties
[122] The sample film was examined using an electron microscope to obtain its forming state, size of the nano fiber, network structure, etc. Results are shown in Figs. 2 to 5. The specific surface area of the dissolvable nano web porous film was measured by the BET (Brunauer, Emmett, Teller) method. In this example, the nano fiber had a diameter of about 200 nm, and the porous film had a specific surface area of 110 mVg and porosity of 42%.
[123]
[ 124] (B) Evaluation of dis solvability
[125] The sample film was put in tepid water at 35 0C, and left after being shaken two or three times. Here, the container was carefully shaken such that the film was not stuck on the wall of the container. Then, the dissolvability of the film was evaluated by measuring time taken for complete dissolution of the film. The dissolvability of the film in the oral cavity was determined by putting the sample film in the mouth of an adult male and measuring time taken for complete dissolution of the film by saliva. Results of the dissolvability in tepid water and in the oral cavity are shown in Fig. 8. The porous film having a thickness of 20 μm in this example was completely dissolved within 7 seconds in tepid water and within 8 seconds in the oral cavity.
[126]
[127] Example 2
[128] 1.5wt% avicel was added to 70wt% distilled water, and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, 0.6wt% sucrose fatty acid ester was added to the solution, and completely dissolved therein. Then, 0.3wt% sorbitol, 0.8wt% propylene glycol, and 0.4wt% glycerine were added to the resulting solution, and heated to 70 0C. 23wt% pullulan was slowly added to the heated solution, and stirred to be completely dissolved in the solution. After heating the resulting solution to 80 0C, 0.1 wt% carrageenan, 0.1 wt% locust bean gum (LBG), and 0.1 wt% xanthan gum were added to the heated resulting solution, and completely dispersed and dissolved. After cooling the resulting solution to 4O0C, 0.5wt% aspartame, 0.1wt% acesulfame K, 0.3wt% malic acid, 2wt% menthol, and 0.2wt% citric acid were added thereto, followed by stirring them until they were uniformly dispersed and completely dissolved, thereby preparing a polymer solution.
[129] The solution was kept for 6 hours or more to remove air bubbles. Then, the solution was coated to a thin film and cast to produce a film having a thickness in the range of 10-50/M. The resulting nonporous film was dried by heated air at about 60- 1000C and kept in a thermo-hygrostat at a temperature of 25 0C and a relative humidity of 45% for 24 hours to be stabilized. The nonporous film had a moisture content of about 1 l~13wt%. The nonporous film was cut into pieces 2 cm wide by 3 cm long.
[130] The nonporous film produced in this example was evaluated by the same method as in Example 1 with respect to film forming properties and dissolvability (evaluation of surface-active reaction of nonporous film). A film-forming state of the film was observed by an electron microscope, of which results are shown in Figs. 6 and 7. Results of the dissolvability in tepid water and in the oral cavity are shown in Fig. 8. The nonporous film having a thickness of 20 μm was completely dissolved within 33 seconds in tepid water and within 35 seconds in the oral cavity.
[131]
[132] Example 3
[133] 0.6wt% sucrose fatty acid ester was added to 71.41wt% distilled water, and sufficiently uniformly dispersed at room temperature. Then, 0.3wt% sorbitol, 0.9wt% propylene glycol and 0.4wt% glycerine were added to the resulting solution, and heated to 7O0C. 23wt% hydroxypropylmethyl cellulose (HPMC) was slowly added to the heated solution, and stirred to be completely dissolved in the solution. After heating the resulting solution to 8O0C, 0.1 wt% carrageenan, 0.1 wt% locust bean gum (LBG), and 0.1 wt% xanthan gum were added thereto, and completely dispersed and dissolved. After cooling the resulting solution to 4O0C, 0.45wt% aspartame, 0.04wt% acesulfame K, 0.3wt% malic acid, 2wt% menthol and 0.3wt% citric acid are added thereto, stirring to be uniformly dispersed were added thereto, followed by stirring them until they were uniformly dispersed and completely dissolved, preparing a polymer solution. The porous film was produced by the same method as in Example 1 except using the solution prepared in example 3, a nozzle tip having an inner diameter of 0.1-10 mm, and electric field having a voltage of 10-25 kV.
[134]
[135] Example 4 [136] After heating 77wt% distilled water to 7O0C, 21wt% pectin, 0.5wt% carrageenan,
0.5wt% glycerine, 0.2wt% sorbitol, and 0.8wt% propylene glycol were added thereto, and stirred to be uniformly dispersed and completely dissolved, thereby producing a solution. Then, a porous film was formed of the resulting solution by the same method as in Example 3 except using the solution prepared in example 4.
[137]
[138] Examples 5 to 22
[139] In Examples 5 to 22, films were produced using solutions formed of ingredients in Table 1 by the same method as in Example 1. In Table 1, a quantity is expressed by wt% (% by weight).
[140]
[141] Table 1
[Table 1]
Figure imgf000023_0001
In Examples 5 to 22, solutions were prepared using ingredients and content shown in Table 1 by the following process. Avicel was added to distilled water (DW), and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, sucrose fatty acid ester was added to the solution, and completely dissolved therein. (In Examples 10, 16 and 22 where avicel was not used, sucrose fatty acid ester was added to distilled water, and sufficiently dissolved at room temperature for about 10 minutes.) Then, sorbitol, propylene glycol, and glycerine were added to the resulting solution and heated to 7O0C. Pullulan, pectin, and hydroxypropylmethyl cellulose (HPMC) were slowly added to the heated solution, and stirred to be completely dissolved in the solution. After heating the resulting solution to 8O0C, carrageenan, locust bean gum (LBG), xanthan gum and guar gum were added to the heated resulting solution, and completely dispersed and dissolved. After cooling the resulting solution to 4O0C, aspartame, acesulfame K, ethanol, malic acid, and citric acid were sequentially added thereto, followed by stirring them until they were uniformly dispersed and completely dissolved, thereby preparing a polymer solution. A nano web porous film was produced using the solution by the same method as in Example 1.
[143]
[144] Examples 23 to 40
[145] In Examples 23 to 40, films were produced using a solution formed of ingredients in Table 2 by the same method as in Example 1. In Table 2, a quantity is expressed by wt%.
[146]
[147] Table 2
[Table 2]
Figure imgf000025_0001
[148] In Examples 23 to 40, solutions were prepared using ingredients in Table 2 by the following process. Avicel was added to distilled water (DW), and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, sucrose fatty acid ester was added to the solution, and completely dissolved therein. Then, sorbitol, propylene glycol, and glycerine were added to the resulting solution and heated to 7O0C. Pullulan, pectin, and hydroxypropylmethyl cellulose (HPMC) were slowly added to the heated solution, and stirred to be completely dissolved in the solution. After heating the resulting solution to 8O0C, carrageenan, locust bean gum (LBG) and xanthan gum were added to the heated resulting solution, and completely dispersed and dissolved. After cooling the resulting solution to 4O0C, aspartame, acesulfame K, ethanol, malic acid, and citric acid were sequentially added thereto, followed by stirring them until they were uniformly dispersed and completely dissolved, thereby preparing a polymer solution. A nano web porous film was produced using the solution by the same method as in Example 1.
[149]
[150] Examples 41 to 48
[151] In Examples 41 to 48, films were formed using solutions formed of ingredients (medical supplies) in Table 3 by the same method as in Example 1. In Table 3, a quantity is expressed by wt%.
[152]
[153] Table 3
[Table 3]
Figure imgf000027_0001
In Examples 41 to 4% solutions were prepared using ingredients shown in Table 3 by the following process. Sucrose fatty acid ester was added to distilled water heated to 5O0C, and completely dissolved. Then, propylene glycol and glycerine were added to the resulting solution, and slowly heated to 7O0C. Pullulan was slowly added to the heated solution, stirred to be completely dissolved in the solution. After heating the resulting solution to 8O0C, carrageenan, locust bean gum (LBG), and xanthan gum were added to the heated resulting solution, and completely dispersed and dissolved. After cooling the resulting solution to 4O0C, aspartame, acesulfame K, malic acid, menthol, and citric acid were sequentially added thereto. Then, a pharmaceutical active agent (e.g., dextromethorphan HBr in Example 41, phenylephrine HCl in Example 42, alkylamines chloropheniramine in Example 43, loperamide HCl in Example 44, Nicotine for Example 45, magnesium stearate in Example 46, oxybutynin in Example 47, and extradiol in Example 48) was added to the solution. The solution was stirred until all ingredients were uniformly dispersed and completely dissolved, thereby preparing a polymer solution. A nano web porous film was produced using the solution by the same method as in Example 1, and cut in pieces of a suitable size capable of ensuring a suitable pharmaceutical content, thereby preparing a pharmaceutical nano web porous film.
[155]
[156] Examples 49 to 66
[157] In Examples 49 to 66, films were produced using solutions (food) formed of ingredients shown in Table 4 by the same method as in Example 1. In Table 4, a quantity is expressed by wt%.
[158]
[159] Table 4
[Table 4]
Figure imgf000029_0001
In Examples 49 to 66, solutions were prepared using ingredients in Table 4 by the following process. Avicel was added to distilled water (DW), and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, sucrose fatty acid ester and polysorbate 80 were added to the solution, and completely dissolved therein. Then, sorbitol, propylene glycol, and glycerine were added to the resulting solution and heated to 7O0C. Pullulan, pectin and hydroxypropylmethyl cellulose (HPMC) were slowly added to the heated solution, and stirred to be completely dissolved in the solution. After heating the resulting solution to 8O0C, carrageenan, locust bean gum (LBG) and xanthan gum were added to the heated resulting solution, and completely dispersed and dissolved. After cooling the resulting solution to 4O0C, aspartame, acesulfame K, ethanol, malic acid, citric acid, menthol, a mint flavored powder, a lemon flavor, a citrus spice mint flavor, a spearmint flavor, a coffee flavor, a peach flavor, a natural orange oil flavor, a cheery flavor, and a strawberry flavor were sequentially added thereto, followed by stirring them until they were uniformly dispersed and completely dissolved, thereby preparing a polymer solution. A nano web porous film was produced using the solution by the same method as in Example 1.
[161]
[ 162] Examples 67 to 72
[163] In Examples 67 to 72, films were formed using solutions formed of ingredients (for oral cleansing) in Table 5 by the same method as in Example 1. In Table 5, a quantity is expressed by wt%.
[164]
[165] Table 5
[Table 5]
Figure imgf000031_0001
In Examples 67 to 72, solutions were prepared using ingredients shown in Table 5 by the following process. Avicel was added to distilled water (DW), and sufficiently uniformly dispersed at room temperature for about 10 minutes. Also, sucrose fatty acid ester and polysorbate 80 were added to the solution, and completely dissolved therein. Then, sorbitol, propylene glycol, and glycerine were added to the resulting solution and heated to 7O0C. Pullulan was slowly added to the heated solution, and stirred to be completely dissolved in the solution. After heating the resulting solution to 8O0C, carrageenan, locust bean gum (LBG), xanthan gum and guar gum are added thereto, and completely dispersed and dissolved. After cooling the resulting solution to 4O0C, aspartame, acesulfame K, ethanol, malic acid, citric acid, menthol, eucalyptus oil, cetylpyridinium chloride, methyl salicylate, a mint flavored powder, a citrus spice mint flavor, a spearmint flavor, and a peach flavor were added thereto, followed by stirring them until they were uniformly dispersed and completely dissolved, thereby preparing a polymer solution. A nano web porous film was produced using the solution by the same method as in Example 1.
[167] While the present invention has been shown and described in connection with the preferred embodiments, it will be apparent to those skilled in the art that modifications and variations can be made without departing from the spirit and scope of the invention as defined by the appended claims.
[168]

Claims

Claims
[1] A dissolvable nano web porous film, wherein the nano web porous film has a network structure formed by stacking nano fibers, the nano fibers having a thickness of 10-50,000 nm and formed of a composition comprising a nano fiber forming polymer, a gelling agent, and a plasticizer.
[2] The porous film according to claim 1, wherein the composition further comprises an active component and/όr additives.
[3] The porous film according to claim 1, wherein the nano fiber forming polymer has an average molecular weight of 1,000-2,000,000 g/mol.
[4] The porous film according to claim 1, wherein the nano fiber forming polymer is at least one material selected from the group consisting of pullulan, hydrox- ypropylmethyl cellulose (HPMC), hydroxymethyl cellulose (HMC), hy- droxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC), ethyl cellulose (EC), methyl cellulose (MC), hydroxypropylmethyl cellulose phthalate (HPMCP), hyiroxypropylmethyl cellulose acetate succinate (HPMCAS), cellulose acetate phthalate (CAP), carboxymethyl cellulose (CMC), polyvinyl pyrrolidone (PVP), polyvinyl alcohol (PVA), sodium alginate, polyethylene glycol, locust bean gum, xanthan gum, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methyl methacrylate copolymer, amylose, dextrin, chitin, chitosan, levan, elsinan, collagen, gelatin, glucan, high amylose starch (corn starch, potato starch, wheat starch, rice starch, mung-bean starch, yellow bean starch, etc.), ester derivatives of starch, soy protein isolate, whey protein isolate, casein, gellan and pectin, and is added in an amount of l~99wt% to a total amount of the composition.
[5] The porous film according to claim 1, wherein the gelling agent is at least one material selected from the group consisting of locust bean gum, xanthan gum, carrageenan, gelatin, gellan gum, agar, alginates, guar gum, starch, pectin, ethyl cellulose, methyl cellulose, sodium carboxymethyl cellulose and polyethylene glycol, and is added in an amount of 0. l~50wt% to 100wt% nano fiber forming polymer.
[6] The porous film according to claim 1, wherein the plasticizer is at least one material selected from the group consisting of sorbitol, mannitol, glycerin, propylene glycol, polyethylene glycol, fatty acid glycerol monoester, sugar alcohol, monosaccharide, oligosaccharide, Methylene glycol, myvacet, triethyl citrate, triacetin, propylene glycol monocaprylate, propylene glycol dicaprylate and miglyol, all being organic compounds of polyol containing at least one hjdroxyl group, and is added in an amount of 0. l~40wt% to 100wt% nano fiber forming polymer.
[7] The porous film according to claim 2, wherein the active component is at least one selected from the group consisting of: α-adrenergic agonists; β-adrenergic agonists; α-adrenergic blocking agents; β-adrenergic blocking agents; alcohol prohibition agents; aldose-reductase inhibitors; anabolic agents; narcotic analgesics; derivatives of morphine; non-narcotic analgesics, preferably, salicylates and derivatives thereof; androgens; anesthetics; appetite inhibitors; anthelmintics (taenia, nematode, filarial, schistosome, and fluke eliminating active agents); antiacne agents; antiallergic agents; antiamebic drugs (ameba eliminating agents); antiandrogens; angina therapeutic agents; antiarrhythmic drugs; antiarteriosclerotic agents; antiarthritic and antirheumatic agents; antimicrobial agents (antibiotics), preferably, aminoglycosides, amphenicols, ansamycins, β-lactams (particularly, carbapenems, cephalosporins, cephamycins, monolactams, oxacephems, and penicillins), lincosamides, macrolides, polypeptides, and tetracyclines; synthetic antimicrobials, preferably, 2,4-diaminopyrimidines, nitrofurans, quinolones and quinolone analogues, sulfonamides, and sulfones; anticholinergics; anticonvulsants; antidepressants, preferably, bicyclic antidepressants, hyirazides, hydrazines, pyrrolidones, tetracycline antidepressants; tricyclic antidepressants, polycyclic imides; antidiabetic agents, preferably, biguanides, sulfonylurea derivatives; antidiarrheals; antidiuretic agents; antiestrogens; antifungal agents/ fungicides, preferably, polyenes; synthetic antifungal agent/ fungicide, preferably, allyl amines, imidazoles, triazoles; antiglaucomatous agents; antigonado-trophins; antigout agents; antihistamines, preferably, alkylamine derivatives, aminoalkyl ethers, ethylenediamine derivatives, piperazines, tricyclic compounds (particularly, phe- nothiazine); anti-hyperlipoproteinemia agents (fat inhibitors), preferably, aryloxy alkane acid derivatives (particularly, clofibric acid derivatives and analogues), bile acid- masking materials, HMG-CoA-reductase inhibitors, nicotinic acid derivatives, thyroid hormones and analogues thereof; antihypertensive drugs/ hypotensives, preferably, benzothiadiazine derivatives, N-car- boxylalkyl- (peptide/lactam) derivatives, guanidine derivatives, hydrazines/ ph- thalazins, imidazole derivatives, quaternary ammonium compounds, quinazoline derivatives, reserpine derivatives, sulfonamide derivatives; antihyperthyroid agents; antihypotensive agents; antihypothyroid agents; non-steroidal antiinflammatory drugs (antiphlogistics), preferably, aminoarylcarboxyl acid, arylacetic acid, arylbutyric acid, arylcaboxylic acid, arylpropionic acid derivatives, pyrazoles, pyrazolones, salicylic acid derivatives, thiazine carboxamide; antimalarial drugs, preferably, quinines, salts thereof, acids thereof and derivatives thereof; antimigraine drugs; retching inhibitors; antineoplastic drugs, preferably, alkylating drugs (particularly, alkyl sulfonates, aziridines, ethylenimines, methyl melamines, nitrogen mustard gases, nitrosoureas); antibiotics, antimetabolic agents (particularly, folinic acid analogues, purine analogues, pyrimidine analogues), enzymes, interferons, interleukins; hormonal antineoplastics, preferably, androgens, antiadrenalines, antiandrogens, antiestrogens (particularly, aromatase inhibitors); antineoplastic food acϋtives; antiparkinsonian agents; antipheochromocytoma agents; antipneumocystis agents; prostatic hypertrophy therapeutic agents; protozoacides, preferably, an- tileishmania, antitrichomonal and anti-trypanosoma drugs; antipruriginous agents; antipsoriasis drugs; antineuroleptic agents, preferably, butyrophenones, phenothiazines, thioxanthenes, tricyclic drugs, 4-arylpiperazines, 4-arylpiperidines; antipyretics; antirickettsia agents; antiseborrheic agents; antiseptics, preferably, guanidines, halogens and halogen compounds, nitrofurans, phenols, quinolines; anticonvulsants/convulsion inhibitors; antithrombotics; antitussives; antiulcer drugs; uric acid eliminating agents (antiurolithiasis agents); antiophidicas; antiviral drugs, preferably, purines, pyrimidinones; anxiolytic, preferably, arylpiperazines, benzodiazepine derivatives, carbamates; benzodiazepine antagonists; bronchodilators, preferably, ephedrine derivatives, quaternary ammonium compounds, xanthine derivatives; calcium channel blockers, preferably, arylalkylamines, dihjdropyridine derivatives, piperazine derivatives; calcium modulators; cardiac stimulants; chelate or complex forming agents; cholecystokinin antagonists; antigallstone agents; bile secretagogues; parasympathomimetic drugs; cholinesterase inhibitors; cholinesterase rehabilitation materials; CNS stimulants; decongestants; tooth decay prevention agents; decolorants; diuretics, preferably, organomercury compounds, pteridines, purines, steroids, sulfonamides, uracils; dopamine receptor agonists; ectoparasite eliminating agents; enzymes, preferably, digestive enzymes, penicillin in- activating enzymes, proteolytic enzymes; enzyme inducers; steroidal and nonsteroidal estrogens; gastric acid secretion inhibitors; glucocorticoids; gonadotropic activators; gonadotropins; growth hormone inhibitors; growth hormone releasing factors; growth stimulants; anticoagulants; heparin antagonists; liver protective agents; liver disease therapeutic agents; immune modulators; immune inhibitors; ion exchange resins; prolactins; LH-RH agonists; lipotropic agents; lupus erythematosus eliminating agents; mineralo- corticoids; miotic agents; monoamine oxidase inhibitors; mucolytic agents; muscle relaxants; narcotic antagonists; neuroprotective agents; nootropics; ophthalmic agents; ovarian hormones; oxytocic agents; pepsin inhibitors; peristaltic stimulants; progestogens; prolactin inhibitors; prostaglandins and analogues thereof; protease inhibitors; respiratory stimulants; hardening agents; sedatives/ somnifacients, preferably, non-cyclic ureides, alcohols, amides, barbiturates acid derivatives, benzodiazepine derivatives, bromides, carbamates, chloral derivatives, piperidinediones, quinazolone derivatives; thrombolytic agents; thyroid hormones; uricosuric agents; vasodilators (cerebrum); vasodilators (coronary arteries); vasodilators (peripheral nerve); blood vessel protective agents; vitamins, provitamins, vitamin extracts, vitamin derivatives; and trauma therapeutic agents.
[8] The porous film according to claim 7, wherein the active component is added in an amount of 0.01~40wt% in the final nano web porous film.
[9] The porous film according to claim 2, wherein the additive is at least one selected from the group consisting of: saccharides such as white sucrose, maltose, fructose, galactooligosaccharide, galactose, fructooligosaccharide, dextrin, ion starch syrup, malt syrup, lactose, glucose, sorbitol, mannitol, xylitol, inositol, etc.; saliva stimulating agents such as citric, lactic, maleic, succinic, ascorbic, adipic, fumaric and tartaric acids; sweeteners such as monosaccharide, disaccharide, ribose, glucose, mannose, galactose, fructose, sucrose, maltose, invert sugars, corn syrup solids, glythyl retinoate, white sugars, water soluble artificial sweeteners; thickening agents such as methyl cellulose, carboxyl methyl cellulose, etc.; masking agents such as citric, tartaric and fumaric acids; dyes; coloring agents such as natural pigments, tar pigments, etc.; refreshing agents such as menthol, peppermint oil, peppermint, spearmint, etc.; flavoring agents such as natural or synthetic fragrances; and nutrient, plant extracts, herbal components, vitamins, minerals, nitroglycerin, catechin, polyphenols, enzymes, emulsifier, seasonings, fragrances, fats and oil, adenosine, coenzyme QlO, vitamin E, vitamin C, fibroin, amyloglucosidase, albutin, hyaluronic acid, D/
DL-panthenol, neomycin, and hydrocortisone acetate. [10] The porous film according to claim 9, wherein the additive is added in an amount of 0.01~40wt% in the final nano web porous film. [11] The porous film according to claim 1, wherein the porous film has porosity of
10-90%. [12] The porous film according to claim 1, wherein the porous film has a specific surface area of 0.1-1,000 mVg. [13] The porous film according to claim 1, wherein the porous film has a thickness of
5-500 [M. [14] A method of preparing a dissolvable nano web porous film, comprising: producing a polymer melt or a polymer solution of a composition comprising a nano fiber forming polymer, a gelling agent and a plasticizer, as essentical components and an active component, and additives, as optional components; spinning the polymer melt or solution to form a nano web porous film having nano webs stacked in a network structure; drying the nano web porous film; and stabilizing the nano web porous film. [15] The method according to claim 14, wherein the spinning step is performed by one method selected from the group consisting of electro spinning, spun-lace, spun-bond, melt-blown, and flash spinning. [16] The method according to claim 14, further comprising compressing the nano web porous film after the spinning.
PCT/KR2007/004342 2007-08-10 2007-09-07 Dissolvable nano web porous film and method of preparing the same WO2009022761A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP07808135.3A EP2187970A4 (en) 2007-08-10 2007-09-07 Dissolvable nano web porous film and method of preparing the same
CN2007801007557A CN102014962B (en) 2007-08-10 2007-09-07 Dissolvable nano web porous film and method of preparing the same
US12/672,950 US20110250256A1 (en) 2007-08-10 2007-09-07 Dissolvable Nano Web Porous Film and Method of Preparing the Same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2007-0080677 2007-08-10
KR20070080677A KR100937625B1 (en) 2007-08-10 2007-08-10 Dissolvable Web Porous Film and Preparing Method Thereof

Publications (1)

Publication Number Publication Date
WO2009022761A1 true WO2009022761A1 (en) 2009-02-19

Family

ID=40350806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/004342 WO2009022761A1 (en) 2007-08-10 2007-09-07 Dissolvable nano web porous film and method of preparing the same

Country Status (5)

Country Link
US (1) US20110250256A1 (en)
EP (1) EP2187970A4 (en)
KR (1) KR100937625B1 (en)
CN (1) CN102014962B (en)
WO (1) WO2009022761A1 (en)

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012003350A1 (en) * 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
WO2012003365A1 (en) * 2010-07-02 2012-01-05 The Procter & Gamble Company Filaments comprising an ingestible active agent nonwoven webs and methods for making same
WO2012003300A3 (en) * 2010-07-02 2012-02-16 The Procter & Gamble Company Filaments comprising a non-perfume active agent nonwoven webs and methods for making same
WO2012003319A3 (en) * 2010-07-02 2012-02-23 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
WO2012003367A3 (en) * 2010-07-02 2012-03-01 The Procter & Gamble Company Method for delivering an active agent
WO2012003351A3 (en) * 2010-07-02 2012-05-10 The Procter & Gamble Company Web material and method for making same
WO2012097763A2 (en) * 2011-01-17 2012-07-26 Elmarco S.R.O. A carrier for oromucosal, especially sublingual administration of physiologically active substances
WO2012125297A1 (en) * 2011-03-01 2012-09-20 The Procter & Gamble Company Porous disintegratable solid substrate for personal health care applications
CN102959148A (en) * 2010-06-29 2013-03-06 花王株式会社 Nanofibre laminate sheet
WO2013035072A1 (en) * 2011-09-08 2013-03-14 Vile Glenn Bioactive nanofibres
JP2013509495A (en) * 2010-07-02 2013-03-14 ザ プロクター アンド ギャンブル カンパニー Method for making a film from a nonwoven web
CN102985603A (en) * 2010-07-02 2013-03-20 宝洁公司 Filaments comprising an active agent nonwoven webs and methods for making same
WO2012003349A3 (en) * 2010-07-02 2013-04-18 The Procter & Gamble Company Dissolvable fibrous web structure article comprising active agents
US9018193B2 (en) 2010-09-13 2015-04-28 Bev-Rx, Inc. Aqueous drug delivery system
EP2765160A4 (en) * 2011-10-04 2015-06-17 Genic Co Ltd Hydrogel composition for a mask base and method for manufacturing a hydrogel using same
CN105727358A (en) * 2016-02-23 2016-07-06 广西易得佳医疗器械有限公司 Drug-loaded biopolymer compound nanofiber membrane and preparation method thereof
CN107177049A (en) * 2017-05-23 2017-09-19 佛山市因诺维生物科技有限公司 A kind of HPG nano cellulose composite film and preparation method thereof
US9827173B2 (en) 2014-05-05 2017-11-28 The Procter & Gamble Company Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom
WO2018005571A1 (en) 2016-06-30 2018-01-04 The Gillette Company Llc Shaving aid for razor cartridges comprising a nano-filament comprisng a core and sheath
WO2018005574A1 (en) 2016-06-30 2018-01-04 The Gillette Company Llc Shaving aid for razor cartridges comprising a nano-filament
WO2018005148A1 (en) 2016-06-30 2018-01-04 The Gillette Company Llc Shaving aid for razor cartridges comprising filaments
US9861558B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating
US9861559B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating
US9867762B2 (en) 2014-05-05 2018-01-16 The Procter & Gamble Company Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating
US9877899B2 (en) 2014-05-05 2018-01-30 The Procter & Gamble Company Consumer product comprising a fibrous web structure with a silicone conditioning agent coating
US9937111B2 (en) 2014-05-05 2018-04-10 The Procter & Gamble Company Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating
CN109966540A (en) * 2019-04-04 2019-07-05 武汉大学 A kind of preparation method and application of nano-chitosan compound calcium alginate medical dressing
WO2019222125A1 (en) * 2018-05-14 2019-11-21 The Procter & Gamble Company Unit-dose oral care compositions
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11053466B2 (en) 2018-01-26 2021-07-06 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
US11142730B2 (en) 2018-01-26 2021-10-12 The Procter & Gamble Company Water-soluble articles and related processes
US11193097B2 (en) 2018-01-26 2021-12-07 The Procter & Gamble Company Water-soluble unit dose articles comprising enzyme
RU2782456C2 (en) * 2016-12-23 2022-10-27 Контипро A.С. Ophthalmic preparation
US11505379B2 (en) 2018-02-27 2022-11-22 The Procter & Gamble Company Consumer product comprising a flat package containing unit dose articles
US11679066B2 (en) 2019-06-28 2023-06-20 The Procter & Gamble Company Dissolvable solid fibrous articles containing anionic surfactants
IT202200004418A1 (en) * 2022-03-08 2023-09-08 Bakel S R L COMPOSITION TO BE ELECTROWIRED
US11753608B2 (en) 2018-01-26 2023-09-12 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
US11859338B2 (en) 2019-01-28 2024-01-02 The Procter & Gamble Company Recyclable, renewable, or biodegradable package
US11878077B2 (en) 2019-03-19 2024-01-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
US11911492B2 (en) 2018-05-14 2024-02-27 The Procter & Gamble Company Oral care compositions comprising metal ions
US11925698B2 (en) 2020-07-31 2024-03-12 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765170B2 (en) 2008-01-30 2014-07-01 The Procter & Gamble Company Personal care composition in the form of an article
MX2010011378A (en) 2008-04-16 2010-11-12 Procter & Gamble Non-lathering personal care composition in the form of an article.
CA2723307C (en) * 2008-05-05 2017-08-22 Euro-Celtique S.A. Tamper resistant opioid composition for treating skin lesions
MX339322B (en) 2009-12-08 2016-05-20 Procter & Gamble A porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres.
WO2011103152A1 (en) 2010-02-16 2011-08-25 The Procter & Gamble Company A porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
US20140378661A1 (en) * 2011-04-20 2014-12-25 Trustees Of Tufts College Molded regenerated silk geometries using temperature control and mechanical processing
US8939957B2 (en) 2011-04-29 2015-01-27 The Procter & Gamble Company Absorbent article with leg gasketing cuff
JP2014516758A (en) 2011-06-21 2014-07-17 ザ プロクター アンド ギャンブル カンパニー Absorbent article with gathered waistband and leg cuff
WO2012177400A1 (en) 2011-06-21 2012-12-27 The Procter & Gamble Company Absorbent article with waistband having contraction
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (en) 2011-11-23 2021-12-14 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
JP5964453B2 (en) * 2012-01-04 2016-08-03 ザ プロクター アンド ギャンブル カンパニー Active substance-containing fibrous structure having a plurality of regions having different densities
US9139802B2 (en) * 2012-01-04 2015-09-22 The Procter & Gamble Company Active containing fibrous structures with multiple regions
EP2849702A1 (en) 2012-05-15 2015-03-25 The Procter & Gamble Company Disposable absorbent pants with advantageous stretch and manufacturability features, and methods for manufacturing the same
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX370280B (en) 2012-10-12 2019-12-09 Procter & Gamble Personal care composition in the form of a dissolvable article.
CN102943318A (en) * 2012-11-28 2013-02-27 苏州大学 polyvinyl alcohol (PVA)/sodium carboxy methylated cellulose (Na-CMC) nanofiber, preparation method and application
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR101407922B1 (en) 2013-11-14 2014-06-17 주식회사 서울제약 Porous Orally Disintegrating Film comprising pharmacologically active substance and Precess For Producing thereof
US20150132575A1 (en) * 2013-11-14 2015-05-14 Honeywell International Inc. Luminescent fibers, articles including the same, and methods of forming the same
US20150315350A1 (en) 2014-04-22 2015-11-05 The Procter & Gamble Company Compositions in the Form of Dissolvable Solid Structures
EP3134564B1 (en) * 2014-04-22 2018-06-20 The Procter and Gamble Company Filaments and fibrous structures employing same
GB2535666B (en) 2014-04-30 2017-03-29 Matoke Holdings Ltd Antimicrobial compositions
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN107106720B (en) * 2014-06-05 2020-06-16 约翰内斯堡威特沃特斯兰德大学 Wound dressing
CA2977387C (en) * 2015-03-04 2020-04-28 The Procter & Gamble Company Fibrous elements, fibrous structures, and products comprising a deterrent agent and methods for making same
CN107427396A (en) 2015-03-18 2017-12-01 宝洁公司 Absorbent article with leg cuff
EP3270852B1 (en) 2015-03-18 2019-08-21 The Procter and Gamble Company Absorbent article with waist gasketing element and leg cuffs
EP3270855B1 (en) 2015-03-18 2020-02-26 The Procter and Gamble Company Absorbent article with leg cuffs
US10524963B2 (en) 2015-03-18 2020-01-07 The Procter & Gamble Company Absorbent article with waist gasketing element and leg cuffs
WO2016149589A1 (en) 2015-03-18 2016-09-22 The Procter & Gamble Company Absorbent article with leg cuffs
US10524962B2 (en) 2015-03-18 2020-01-07 The Procter & Gamble Company Absorbent article with waist gasketing element and leg cuffs
JP6518783B2 (en) 2015-03-18 2019-05-22 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company Absorbent article comprising a waist gasket element and a leg cuff
US10716716B2 (en) 2015-03-18 2020-07-21 The Procter & Gamble Company Absorbent article with leg cuffs
WO2016149593A1 (en) 2015-03-18 2016-09-22 The Procter & Gamble Company Absorbent article with waist gasketing element and leg cuffs
JP2018512917A (en) 2015-03-18 2018-05-24 ザ プロクター アンド ギャンブル カンパニー Absorbent article with leg cuff
KR101692515B1 (en) * 2015-04-06 2017-01-03 동국대학교 산학협력단 Biodegradable Ultraviolet Light Screening Packaging Film Comprising Biopolymers and Grapefruit Seed Extract, and Manufacturing Method Thereof
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN105039139B (en) * 2015-09-16 2017-11-21 烟台森森环保科技有限公司 A kind of microculture film and microculture recovery system
CN105663025A (en) * 2016-02-29 2016-06-15 浙江工业大学 Drug-containing microfilament and preparation method thereof
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN106436021A (en) * 2016-11-18 2017-02-22 天津捷盛东辉保鲜科技有限公司 Edible food fresh keeping electrospinning fiber membrane
CA3046725A1 (en) 2017-01-11 2018-07-19 Ferring B.V. A fast disintegrating pharmaceutical composition
JP7074970B2 (en) 2017-01-13 2022-05-25 ルナ ラブズ ユーエスエー, エルエルシー Specimen recovery kit containing soluble nanofiber material and the same material for high efficiency sample recovery
MX2019008761A (en) 2017-01-27 2019-09-18 Procter & Gamble Compositions in the form of dissolvable solid structures comprising effervescent agglomerated particles.
EP3573593B1 (en) 2017-01-27 2023-08-30 The Procter & Gamble Company Compositions in the form of dissolvable solid structures
KR101888616B1 (en) * 2017-02-21 2018-08-14 울산과학기술원 Manufacturing method of flexible transparent film and flexible transparent substrate thereof
WO2018195048A1 (en) * 2017-04-17 2018-10-25 Rowan University Solution blow spun protein-based polymer fibers and products comprising same
WO2018213003A1 (en) 2017-05-16 2018-11-22 The Procter & Gamble Company Conditioning hair care compositions in the form of dissolvable solid structures
CN108998841A (en) * 2017-06-07 2018-12-14 南京理工大学 A kind of preparation method of porous polypropylene nitrile nanofibre
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
KR102062683B1 (en) 2018-05-23 2020-01-06 한국화학연구원 Multilayer Film for Oxygen Barrier and Preparation Methodfor Thereof
CN110684360A (en) * 2018-07-04 2020-01-14 长春工业大学 Preparation method of gelatin-based photochromic film for inkless printing
JP1629688S (en) 2018-07-16 2019-04-15
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
JP2022529186A (en) * 2019-04-18 2022-06-17 ナショナル・インスティテュート・オブ・テクノロジー・ルールケーラー Self-assembled nanofibers as a hemostatic agent
EP3993757A1 (en) 2019-07-03 2022-05-11 The Procter & Gamble Company Fibrous structures containing cationic surfactants and soluble acids
CN110551303B (en) * 2019-09-17 2021-08-17 江南大学 Method for preparing flexible conductive silk fibroin membrane by enzyme method
USD939359S1 (en) 2019-10-01 2021-12-28 The Procter And Gamble Plaza Packaging for a single dose personal care product
US11597191B2 (en) 2019-10-14 2023-03-07 The Procter & Gamble Company Biodegradable and/or home compostable sachet containing a solid article
CN112774457B (en) * 2019-11-01 2022-08-19 中国石油化工股份有限公司 Polymer microfiltration membrane and preparation method and application thereof
EP4061320A1 (en) 2019-11-20 2022-09-28 The Procter & Gamble Company Porous dissolvable solid structure
WO2021113211A1 (en) 2019-12-01 2021-06-10 The Procter & Gamble Company Hair conditioner compositions with a preservation system containing sodium benzoate and glycols and/or glyceryl esters
CN111218013B (en) * 2020-01-22 2022-08-23 上海应用技术大学 Preparation method and application of crosslinked polymer
CN111549446A (en) * 2020-03-02 2020-08-18 深圳市捷安纳米复合材料有限公司 Virus-killing non-woven fabric, preparation process thereof and protective clothing using non-woven fabric
USD962050S1 (en) 2020-03-20 2022-08-30 The Procter And Gamble Company Primary package for a solid, single dose beauty care composition
USD941051S1 (en) 2020-03-20 2022-01-18 The Procter And Gamble Company Shower hanger
USD965440S1 (en) 2020-06-29 2022-10-04 The Procter And Gamble Company Package
CN111662461A (en) * 2020-07-10 2020-09-15 上海海洋大学 Preparation method and application of gelatin guanidino derivative
MX2023001043A (en) 2020-08-11 2023-02-16 Procter & Gamble Clean rinse hair conditioner compositions containing brassicyl valinate esylate.
EP4196233A1 (en) 2020-08-11 2023-06-21 The Procter & Gamble Company Moisturizing hair conditioner compositions containing brassicyl valinate esylate
WO2022036354A1 (en) 2020-08-11 2022-02-17 The Procter & Gamble Company Low viscosity hair conditioner compositions containing brassicyl valinate esylate
WO2022033743A1 (en) 2020-08-14 2022-02-17 Re-Organic As Method to disperse nano-cellulose in polymers, and derived products
MX2023005792A (en) 2020-12-01 2023-05-29 Procter & Gamble Aqueous hair conditioner compositions containing solubilized anti-dandruff actives.
CN112501122A (en) * 2020-12-09 2021-03-16 河南大学 Method for separating and extracting tumor cells
KR20220089239A (en) * 2020-12-21 2022-06-28 현대자동차주식회사 Double-crosslinked cellulose nanofiber film with high strength and high transmittance and method for manufacturing the same
CN113234260B (en) * 2021-06-04 2023-06-13 重庆工商大学 Preparation method of guar gum base nano composite film
CN113445097B (en) * 2021-07-23 2022-09-20 中国科学院青海盐湖研究所 Fiber mesh-shaped magnesium oxide film and preparation method and application thereof
CN113957607A (en) * 2021-10-22 2022-01-21 内蒙古工业大学 Nano composite protein fiber membrane mask and preparation method thereof
CN115747992A (en) * 2022-11-21 2023-03-07 江苏康溢臣生命科技有限公司 High-protein-content antibacterial thermoregulation cellulose fiber and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1011516A1 (en) * 1997-06-06 2000-06-28 The Procter & Gamble Company A delivery system for a tooth whitener using a strip of material having low flexural stiffness
EP1022587A1 (en) * 1997-04-04 2000-07-26 Fuji Photo Film Co., Ltd. Antireflection films and image display device containing the same
WO2001025316A1 (en) * 1999-10-05 2001-04-12 Commonwealth Scientific And Industrial Research Organisation Three dimensional array films
WO2001092381A1 (en) * 1999-12-07 2001-12-06 William Marsh Rice University Oriented nanofibers embedded in polymer matrix

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US6685956B2 (en) * 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
US20060057207A1 (en) * 2001-11-30 2006-03-16 Pfizer Inc Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
WO2006106514A2 (en) * 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
US20070042023A1 (en) * 2005-08-22 2007-02-22 National Starch And Chemical Investment Holding Corporation Dissolvable film
US20100018641A1 (en) * 2007-06-08 2010-01-28 Kimberly-Clark Worldwide, Inc. Methods of Applying Skin Wellness Agents to a Nonwoven Web Through Electrospinning Nanofibers

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1022587A1 (en) * 1997-04-04 2000-07-26 Fuji Photo Film Co., Ltd. Antireflection films and image display device containing the same
EP1011516A1 (en) * 1997-06-06 2000-06-28 The Procter & Gamble Company A delivery system for a tooth whitener using a strip of material having low flexural stiffness
WO2001025316A1 (en) * 1999-10-05 2001-04-12 Commonwealth Scientific And Industrial Research Organisation Three dimensional array films
WO2001092381A1 (en) * 1999-12-07 2001-12-06 William Marsh Rice University Oriented nanofibers embedded in polymer matrix

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2187970A4 *

Cited By (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102959148A (en) * 2010-06-29 2013-03-06 花王株式会社 Nanofibre laminate sheet
CN102959148B (en) * 2010-06-29 2016-07-06 花王株式会社 Nanofibre laminate sheet
US10912738B2 (en) 2010-07-02 2021-02-09 The Procter & Gamble Company Methods of delivering an oral care active by administering oral care articles comprising a filament
US20120172831A1 (en) * 2010-07-02 2012-07-05 Trevor John Darcy Methods of Delivering a Health Care Active by Administering Personal Health Care Articles Comprising a Filament
WO2012003319A3 (en) * 2010-07-02 2012-02-23 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
WO2012003367A3 (en) * 2010-07-02 2012-03-01 The Procter & Gamble Company Method for delivering an active agent
US20120058166A1 (en) * 2010-07-02 2012-03-08 Glenn Jr Robert Wayne Filaments comprising a non-perfume active agent nonwoven webs and methods for making same
WO2012003351A3 (en) * 2010-07-02 2012-05-10 The Procter & Gamble Company Web material and method for making same
WO2012003360A3 (en) * 2010-07-02 2012-05-18 The Procter & Gamble Company Detergent product
US11970789B2 (en) 2010-07-02 2024-04-30 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
US11964059B2 (en) 2010-07-02 2024-04-23 The Procter & Gamble Company Methods of delivering an oral care active by administering oral care articles comprising a filament
US20120237576A1 (en) * 2010-07-02 2012-09-20 Gregory Charles Gordon Filaments comprising an active agent nonwoven webs and methods for making same
US11944693B2 (en) 2010-07-02 2024-04-02 The Procter & Gamble Company Method for delivering an active agent
US11944696B2 (en) 2010-07-02 2024-04-02 The Procter & Gamble Company Detergent product and method for making same
CN102959150A (en) * 2010-07-02 2013-03-06 宝洁公司 Filaments comprising an ingestible active agent nonwoven webs and methods for making same
US20120027838A1 (en) * 2010-07-02 2012-02-02 Gregory Charles Gordon Filaments comprising an ingestible active agent nonwoven webs and methods for making same
CN102971408A (en) * 2010-07-02 2013-03-13 宝洁公司 Detergent product
CN102971453A (en) * 2010-07-02 2013-03-13 宝洁公司 Filaments comprising a non-perfume active agent nonwoven webs and methods for making same
CN102970987A (en) * 2010-07-02 2013-03-13 宝洁公司 Methods of delivering a health care active by administering personal health care articles comprising a filament
US11434586B2 (en) 2010-07-02 2022-09-06 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
JP2013509495A (en) * 2010-07-02 2013-03-14 ザ プロクター アンド ギャンブル カンパニー Method for making a film from a nonwoven web
CN102985603A (en) * 2010-07-02 2013-03-20 宝洁公司 Filaments comprising an active agent nonwoven webs and methods for making same
CN103003476A (en) * 2010-07-02 2013-03-27 宝洁公司 Web material and method for making same
CN103025929A (en) * 2010-07-02 2013-04-03 宝洁公司 Filaments comprising an active agent nonwoven webs and methods for making same
WO2012003349A3 (en) * 2010-07-02 2013-04-18 The Procter & Gamble Company Dissolvable fibrous web structure article comprising active agents
JP2013532171A (en) * 2010-07-02 2013-08-15 ザ プロクター アンド ギャンブル カンパニー Dissolvable fibrous web structure article containing an active agent
CN103282015A (en) * 2010-07-02 2013-09-04 宝洁公司 Dissolvable fibrous web structure article comprising active agents
US20130253017A1 (en) * 2010-07-02 2013-09-26 The Procter & Gamble Company Methods of Delivering a Health Care Active by Administering Personal Health Care Articles Comprising a Filmament
US8785361B2 (en) 2010-07-02 2014-07-22 The Procter & Gamble Company Detergent product and method for making same
JP2014237655A (en) * 2010-07-02 2014-12-18 ザ プロクター アンド ギャンブルカンパニー Dissolvable fibrous web structure article comprising active agents
AU2011272839B2 (en) * 2010-07-02 2015-04-02 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
US11021812B2 (en) 2010-07-02 2021-06-01 The Procter & Gamble Company Filaments comprising an ingestible active agent nonwoven webs and methods for making same
RU2553295C2 (en) * 2010-07-02 2015-06-10 Дзе Проктер Энд Гэмбл Компани Detergent and methods of its production
US20210154150A1 (en) * 2010-07-02 2021-05-27 The Procter & Gamble Company Methods Of Delivering An Oral Care Active by Administering Oral Care Articles Comprising A Filament
US9074305B2 (en) 2010-07-02 2015-07-07 The Procter & Gamble Company Method for delivering an active agent
RU2555042C2 (en) * 2010-07-02 2015-07-10 Дзе Проктер Энд Гэмбл Компани Method of active substance delivery
US9163205B2 (en) 2010-07-02 2015-10-20 The Procter & Gamble Company Process for making films from nonwoven webs
US9175250B2 (en) 2010-07-02 2015-11-03 The Procter & Gamble Company Fibrous structure and method for making same
JP2016000812A (en) * 2010-07-02 2016-01-07 ザ プロクター アンド ギャンブルカンパニー Detergent product
CN105332075A (en) * 2010-07-02 2016-02-17 宝洁公司 Filaments comprising active agent nonwoven webs and methods for making same
CN102971408B (en) * 2010-07-02 2016-03-02 宝洁公司 Betengent product
WO2012003350A1 (en) * 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
WO2012003365A1 (en) * 2010-07-02 2012-01-05 The Procter & Gamble Company Filaments comprising an ingestible active agent nonwoven webs and methods for making same
CN102959150B (en) * 2010-07-02 2016-08-03 宝洁公司 Comprise and can absorb the long filament of activating agent, non-woven webs and preparation method thereof
US9421153B2 (en) 2010-07-02 2016-08-23 The Procter & Gamble Company Detergent product and method for making same
CN103282015B (en) * 2010-07-02 2016-10-05 宝洁公司 Comprise the soluble fiber web frame goods of activating agent
US9480628B2 (en) 2010-07-02 2016-11-01 The Procer & Gamble Company Web material and method for making same
US20160374906A1 (en) * 2010-07-02 2016-12-29 The Procter & Gamble Company Web Material and Method for Making Same
RU2613316C1 (en) * 2010-07-02 2017-03-15 Дзе Проктер Энд Гэмбл Компани Methods of medical active agent delivery by injection of individual health articles containing filament
JP2017078076A (en) * 2010-07-02 2017-04-27 ザ プロクター アンド ギャンブル カンパニー Dissolvable fibrous web structure article comprising active agents
US10646413B2 (en) 2010-07-02 2020-05-12 The Procter & Gamble Company Web material and method for making same
WO2012003300A3 (en) * 2010-07-02 2012-02-16 The Procter & Gamble Company Filaments comprising a non-perfume active agent nonwoven webs and methods for making same
US20180015048A1 (en) * 2010-07-02 2018-01-18 The Procter & Gamble Company Methods of Delivering a Health Care Active by Administering Personal Health Care Articles Comprising a Filmament
US9801830B2 (en) * 2010-07-02 2017-10-31 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filmament
US10894005B2 (en) 2010-07-02 2021-01-19 The Procter & Gamble Company Detergent product and method for making same
US10517836B2 (en) 2010-07-02 2019-12-31 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filmament
US10449163B2 (en) 2010-07-02 2019-10-22 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
RU2695131C2 (en) * 2010-07-02 2019-07-22 Дзе Проктер Энд Гэмбл Компани Filaments containing active components suitable for oral administration, non-woven fabrics and methods for production thereof
US10045915B2 (en) 2010-07-02 2018-08-14 The Procter & Gamble Company Method for delivering an active agent
RU2640933C1 (en) * 2010-07-02 2018-01-12 Дзе Проктер Энд Гэмбл Компани Filaments containing active components, suitable for oral supplementation, non-woven fabrics and methods of manufacturing them
US9789191B2 (en) 2010-09-13 2017-10-17 Solixa Technologies, Inc. Aqueous drug delivery system
US9018193B2 (en) 2010-09-13 2015-04-28 Bev-Rx, Inc. Aqueous drug delivery system
WO2012097763A2 (en) * 2011-01-17 2012-07-26 Elmarco S.R.O. A carrier for oromucosal, especially sublingual administration of physiologically active substances
US11771648B2 (en) 2011-01-17 2023-10-03 Instar Technologies A.S. Carrier for oromucosal administration of physiologically active substances
WO2012097763A3 (en) * 2011-01-17 2012-09-27 Elmarco S.R.O. A carrier for oromucosal, especially sublingual administration of physiologically active substances
US9789060B2 (en) 2011-01-17 2017-10-17 Instar Technologies A.S. Carrier for oromucosal administration of physiologically active substances
WO2012125297A1 (en) * 2011-03-01 2012-09-20 The Procter & Gamble Company Porous disintegratable solid substrate for personal health care applications
WO2013035072A1 (en) * 2011-09-08 2013-03-14 Vile Glenn Bioactive nanofibres
EP2765160A4 (en) * 2011-10-04 2015-06-17 Genic Co Ltd Hydrogel composition for a mask base and method for manufacturing a hydrogel using same
US10011712B2 (en) 2011-10-04 2018-07-03 Genic Co., Ltd. Hydrogel composition for a mask base and method for manufacturing a hydrogel using same
US9861559B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating
US9861558B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating
US9827173B2 (en) 2014-05-05 2017-11-28 The Procter & Gamble Company Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom
US9937111B2 (en) 2014-05-05 2018-04-10 The Procter & Gamble Company Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating
US9877899B2 (en) 2014-05-05 2018-01-30 The Procter & Gamble Company Consumer product comprising a fibrous web structure with a silicone conditioning agent coating
US9867762B2 (en) 2014-05-05 2018-01-16 The Procter & Gamble Company Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating
CN105727358A (en) * 2016-02-23 2016-07-06 广西易得佳医疗器械有限公司 Drug-loaded biopolymer compound nanofiber membrane and preparation method thereof
WO2018005571A1 (en) 2016-06-30 2018-01-04 The Gillette Company Llc Shaving aid for razor cartridges comprising a nano-filament comprisng a core and sheath
WO2018005148A1 (en) 2016-06-30 2018-01-04 The Gillette Company Llc Shaving aid for razor cartridges comprising filaments
WO2018005574A1 (en) 2016-06-30 2018-01-04 The Gillette Company Llc Shaving aid for razor cartridges comprising a nano-filament
RU2782456C2 (en) * 2016-12-23 2022-10-27 Контипро A.С. Ophthalmic preparation
CN107177049A (en) * 2017-05-23 2017-09-19 佛山市因诺维生物科技有限公司 A kind of HPG nano cellulose composite film and preparation method thereof
US11753608B2 (en) 2018-01-26 2023-09-12 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
US11193097B2 (en) 2018-01-26 2021-12-07 The Procter & Gamble Company Water-soluble unit dose articles comprising enzyme
US11142730B2 (en) 2018-01-26 2021-10-12 The Procter & Gamble Company Water-soluble articles and related processes
US11053466B2 (en) 2018-01-26 2021-07-06 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
US11505379B2 (en) 2018-02-27 2022-11-22 The Procter & Gamble Company Consumer product comprising a flat package containing unit dose articles
US11911492B2 (en) 2018-05-14 2024-02-27 The Procter & Gamble Company Oral care compositions comprising metal ions
US11944694B2 (en) 2018-05-14 2024-04-02 The Procter & Gamble Company Foaming oral care compositions
WO2019222125A1 (en) * 2018-05-14 2019-11-21 The Procter & Gamble Company Unit-dose oral care compositions
US10821056B2 (en) 2018-05-14 2020-11-03 The Procter & Gamble Company Foaming oral care compositions
US10932996B2 (en) 2018-05-14 2021-03-02 The Procter & Gamble Company Oral care compositions comprising fluoride ions
US10835455B2 (en) 2018-05-14 2020-11-17 The Procter & Gamble Company Oral care compositions comprising metal ions
AU2019270966B2 (en) * 2018-05-14 2021-11-11 The Procter & Gamble Company Unit-dose oral care compositions
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11859338B2 (en) 2019-01-28 2024-01-02 The Procter & Gamble Company Recyclable, renewable, or biodegradable package
US11878077B2 (en) 2019-03-19 2024-01-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
CN109966540A (en) * 2019-04-04 2019-07-05 武汉大学 A kind of preparation method and application of nano-chitosan compound calcium alginate medical dressing
US11679066B2 (en) 2019-06-28 2023-06-20 The Procter & Gamble Company Dissolvable solid fibrous articles containing anionic surfactants
US11925698B2 (en) 2020-07-31 2024-03-12 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
WO2023170718A1 (en) * 2022-03-08 2023-09-14 Bakel S.R.L. Composition to be electrospun
IT202200004418A1 (en) * 2022-03-08 2023-09-08 Bakel S R L COMPOSITION TO BE ELECTROWIRED

Also Published As

Publication number Publication date
CN102014962B (en) 2013-04-24
CN102014962A (en) 2011-04-13
EP2187970A4 (en) 2015-06-03
EP2187970A1 (en) 2010-05-26
US20110250256A1 (en) 2011-10-13
KR100937625B1 (en) 2010-01-20
KR20090016203A (en) 2009-02-13

Similar Documents

Publication Publication Date Title
US20110250256A1 (en) Dissolvable Nano Web Porous Film and Method of Preparing the Same
Torres-Martínez et al. A summary of electrospun nanofibers as drug delivery system: Drugs loaded and biopolymers used as matrices
CN100389755C (en) Compositions and methods for mucosal delivery
JP3293862B2 (en) Granular pharmaceutical composition suitable for controlled release of a pharmacologically active substance and process for preparing said composition
CN102548535B (en) Sublingual and buccal film compositions
TWI250029B (en) Water soluble film for oral administration with instant wettability
Goonoo et al. Drug loading and release from electrospun biodegradable nanofibers
CN1747656B (en) Packaging and dispensing of rapid dissolve dosage form
US8840935B2 (en) Orally administrable films and preparation thereof
EP1296661B1 (en) Process of preparation of rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities
US20070042023A1 (en) Dissolvable film
WO2005082048A2 (en) Dissolvable film and method of manufacture
KR102385203B1 (en) Sustained-release injection formulation containing bone morphogenetic protein and hyaluronic acid filler conjugate, and method for producing the same
CN102753196A (en) Ph sensitive compounds in taste masking within oral thin film strips
AU1683988A (en) A spun fibrous cosmetic and method of use
JPH03500164A (en) Rapidly dissolving fibrous pharmaceutical composition and method for producing the same
TW200800305A (en) Encapsulation of lipid-based formulations in enteric polymers
CN102665762A (en) Film-like pharmaceutical dosage forms
JP2007091696A (en) Soluble film
CN100444828C (en) Preparation method of biodegradable polymer pharmaceutical microsphere
JP6444075B2 (en) Patch
CN109771395A (en) A kind of mucous membrane of mouth agent and preparation method thereof containing Quercetin
Sahu et al. Nanofibers in drug delivery
JP2002534373A (en) Composition containing hydroxypropylcellulose and anionic polymer, and its use as a pharmaceutical film coating
RU2777623C1 (en) Injectable composition with suspended release containing a conjugate of a filler with poly-l-lactic acid, a filler with hyaluronic acid and a bioactive material, and a method for its preparation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780100755.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07808135

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2007808135

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007808135

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12672950

Country of ref document: US